var title_f22_7_22640="Illustration of osteoblast and osteoclast formation";
var content_f22_7_22640=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F50298&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F50298&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 589px\">",
"   <div class=\"ttl\">",
"    Schematic illustration of the regulation of osteoblast and osteoclast formation by osteocytes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 569px; height: 317px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Increased production of sclerostin by osteocytes inhibits Wnt signaling and thereby suppresses the differentiation of osteoblasts from mesenchymal stem cells (MSC). Osteocyte-derived RANKL, on the other hand, stimulates osteoclastogenesis from hematopoietic stem cells (HSC). This allows osteocytes to independently alter the rate of remodeling and the balance between formation and resorption in response to mechanical needs or hormonal changes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Jinhu Xiong and Dr. Charles O'Brien, University of Arkansas for Medical Sciences.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22640=[""].join("\n");
var outline_f22_7_22640=null;
var title_f22_7_22641="Tibia PI";
var content_f22_7_22641=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F82795&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F82795&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 489px\">",
"   <div class=\"ttl\">",
"    Tibia (shinbone)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 469px; height: 645px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This drawing shows the location of the tibia, or shinbone.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22641=[""].join("\n");
var outline_f22_7_22641=null;
var title_f22_7_22642="Technetium Tc-99m medronate: Drug information";
var content_f22_7_22642=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Technetium Tc-99m medronate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?22/63/23539?source=see_link\">",
"    see \"Technetium Tc-99m medronate: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F7734546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      CIS-MDP&trade;;",
"     </li>",
"     <li>",
"      DRAXIMAGE&reg; MDP-25;",
"     </li>",
"     <li>",
"      MDP Multidose",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F13207983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Radiopharmaceutical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F13209758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.: 10-20 mCi (370-740 MBq)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      SPECT imaging:",
"     </b>",
"     I.V.: 20-30 mCi (740-1110 MBq)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F13209759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.: 250-300 microcuries/kg (9-11MBq/kg); minimum dose: 0.5-1.0 mCi (20-40 MBq)",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F7734548\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Skeletal imaging agent to detect areas of altered osteogenesis such as an occult fracture, osteomyelitis, stress fracture, avascular necrosis, bone infarcts, bone graft viability, or unexplained bone pain; identify metastatic bone lesions from breast, prostate, and other cancers",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F7734544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Radiopharmaceutical: Use appropriate precaution for handling, disposal, and minimizing exposure to patients and healthcare personnel. Use under supervision of experienced personnel. Should be stored in original lead container or adequate radiation shield.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F13209779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiovascular: Hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Chills, dizziness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Miscellaneous: Hypersensitivity reactions",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F13208647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Radiopharmaceutical: Use appropriate precautions for handling, disposal, and minimizing exposure to patients and healthcare personnel. Use only under supervision of individuals who have received training in the handling of radioactive materials and who are authorized by the applicable regulatory authority.",
"     <b>",
"      Note:",
"     </b>",
"     Contents of kit are not radioactive; however, adequate shielding is required after addition of radioactive material.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hypocalcemia: May form complexes with cations (eg, calcium); use with caution in hypocalcemic patients or in patients at risk of developing hypocalcemia.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F13209658\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13209659\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have not been conducted. There are no adequate and well-controlled studies in pregnant women. Radiopharmaceuticals have the potential to cause fetal harm. Use during pregnancy only if clearly needed.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F13209660\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended (per manufacturer)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13209678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In one report, 1.1% to 2.7% of the administered dose was excreted in breast milk (Ahlgren, 1985), resulting in &lt;100 mrem (1 mSv) effective dose to the infant;  therefore, interruption of breast-feeding is not necessary (Stabin, 2000; U.S. Nuclear Regulatory Commission, 1977).",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Ahlgren L, Ivarsson S, Johansson L, et al, \"Excretion of Radionuclides in Human Breast Milk After the Administration of Radiopharmaceuticals,\"",
"      <i>",
"       J Nucl Med",
"      </i>",
"      , 1985, 26(9):1085-90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?22/7/22642/abstract-text/4032049/pubmed\" id=\"4032049\" target=\"_blank\">",
"        4032049",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Donohoe KJ, Brown ML, Collier BD, et al, \"Society of Nuclear Medicine Procedure Guideline for Bone Scintigraphy,\" 2003. Available at file://interactive.snm.org/docs/pg_ch34_0403.pdf. Last accessed August 31, 2011.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stabin MG and Breitz HB, \"Breast Milk Excretion of Radiopharmaceuticals: Mechanisms, Findings, and Radiation Dosimetry,\"",
"      <i>",
"       J Nucl Med",
"      </i>",
"      , 2000, 41(5):863-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?22/7/22642/abstract-text/10809203/pubmed\" id=\"10809203\" target=\"_blank\">",
"        10809203",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      U.S. Nuclear Regulatory Commission, \"Regulatory Guide 8.39. Release of Patients Administered Radioactive Materials,\" 1977.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16779 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.25.216.6-31B8A52DC8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22642=[""].join("\n");
var outline_f22_7_22642=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7734546\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13207983\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13209758\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13209759\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7734548\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7734544\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13209779\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13208647\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13209658\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13209659\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13209660\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13209678\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16779\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16779|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?22/63/23539?source=related_link\">",
"      Technetium Tc-99m medronate: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_7_22643="North American coral snake (Micrurus fulvius) antivenom: Patient drug information";
var content_f22_7_22643=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   North American coral snake (Micrurus fulvius) antivenom: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/57/34708?source=see_link\">",
"     see \"North American coral snake (Micrurus fulvius) antivenom: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10012735\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat North American coral snake bites.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10012734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701536",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to antivenin (micrurus fulvius) or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to horses or horse serum, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a pain drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10012739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697255",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have hay fever, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697274",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have hives, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10012740\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Allergic side effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10012742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10012737\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10012743\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10012744\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12418 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-FDF33D9AD5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22643=[""].join("\n");
var outline_f22_7_22643=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012735\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012734\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012739\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012740\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012742\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012737\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012743\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012744\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?33/57/34708?source=related_link\">",
"      North American coral snake (Micrurus fulvius) antivenom: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_7_22644="Silver stain lung 1";
var content_f22_7_22644=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F59343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F59343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 569px\">",
"   <div class=\"ttl\">",
"    Silver stain lung 1",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 549px; height: 227px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22644=[""].join("\n");
var outline_f22_7_22644=null;
var title_f22_7_22645="Levalbuterol: Patient drug information";
var content_f22_7_22645=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Levalbuterol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/27/43445?source=see_link\">",
"     see \"Levalbuterol: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/52/18245?source=see_link\">",
"     see \"Levalbuterol: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F187525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Xopenex HFA&trade;;",
"     </li>",
"     <li>",
"      Xopenex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F187526\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Xopenex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F13319005\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10019569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691417",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to open the airways in lung diseases where spasm may cause breathing problems.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10019568\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702372",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to levalbuterol, albuterol, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10019573\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), this drug may sometimes raise blood sugar. Talk with your doctor about how to fine tune this.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697166",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an overactive thyroid, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause nervousness, shakiness, and a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10019574\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose stuffiness.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10019576\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699102",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to get the breathing attack under control.",
"       <b>",
"        Get help right away.",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698996",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Peak flow measurement low.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10019571\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to take this drug as you have been told by your doctor. Do not use more than you were told to use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694895",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For breathing in only by a puffer (inhaler) or as a liquid (solution) by a special machine (nebulizer) into the lungs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake puffer (inhaler) well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695529",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Prepare puffer (inhaler) before first use or when puffer has not been used for 3 days. Spray 4 test sprays into the air.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694373",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A spacer may be used with the puffer (inhaler) for easy use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695186",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are using more than 1 type of puffer (inhaler), ask your doctor which puffer to use first.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rinse out mouth after each use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694582",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your puffer (inhaler) use checked with your doctor at each visit. Read and follow facts on how to use the puffer. Make sure you use the puffer the right way.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10019572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10019577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699539",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store solution in foil pouch at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away any part of opened pouch that is not used after 2 weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699166",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use if solution changes color.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699411",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store puffer (inhaler) at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10019578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10797 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-528937E1C1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22645=[""].join("\n");
var outline_f22_7_22645=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187525\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187526\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13319005\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019569\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019568\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019573\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019574\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019576\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019571\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019572\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019577\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019578\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?42/27/43445?source=related_link\">",
"      Levalbuterol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/52/18245?source=related_link\">",
"      Levalbuterol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_7_22646="Calculator: CDC height for age percentiles for girls (2 to 20 years)";
var content_f22_7_22646=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"CDCHeightForAgeGirls_form\" name=\"CDCHeightForAgeGirls_form\" onkeydown=\"clrResults();\" onkeyup=\"CDCHeightForAgeGirls_fx();\" onreset=\"rrclr();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: CDC height for age percentiles for girls (2 to 20 years)",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_main\">",
"     <center>",
"      <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"       <tr>",
"        <td align=\"right\" width=\"50%\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Input:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Age",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Age_param\" onblur=\"CDCHeightForAgeGirls_fx(); minMaxCheck();\" onchange=\"CDCHeightForAgeGirls_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Age_unit\" onchange=\"CDCHeightForAgeGirls_fx();\" style=\"width:105px;\">",
"              <option value=\"0.0833333333333333|0|mo\">",
"               mo",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|yr\">",
"               yr",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Height",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Height_param\" onblur=\"CDCHeightForAgeGirls_fx(); minMaxCheck();\" onchange=\"CDCHeightForAgeGirls_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Height_unit\" onchange=\"CDCHeightForAgeGirls_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|cm\">",
"               cm",
"              </option>",
"              <option value=\"2.54|0|in\">",
"               in",
"              </option>",
"              <option value=\"100|0|m\">",
"               m",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Results:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Z Score",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Z_Score_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Percentile",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Percentile_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"3\">",
"             &nbsp;",
"             <br/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"center\" colspan=\"3\">",
"             <span class=\"medCalcFontOneBold\">",
"              Decimal Precision:",
"             </span>",
"             <select class=\"medCalcFontSelect\" name=\"decpts\" onchange=\"CDCHeightForAgeGirls_fx();\">",
"              <option>",
"               0",
"              </option>",
"              <option selected=\"selected\">",
"               1",
"              </option>",
"              <option>",
"               2",
"              </option>",
"              <option>",
"               3",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <center>",
"          <span class=\"medCalcFontOne\">",
"           <input name=\"reset\" type=\"reset\" value=\"Reset form\"/>",
"          </span>",
"         </center>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"70%\">",
"      <tr>",
"       <td bgcolor=\"#eeeeee\" width=\"1%\">",
"        <br/>",
"       </td>",
"       <td align=\"left\" bgcolor=\"#eeeeee\">",
"        <span class=\"medCalcFontTitleBox\">",
"         Height for Age Percentile Interpretation",
"        </span>",
"       </td>",
"      </tr>",
"     </table>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <center>",
"      <table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" summary=\"RRTable\">",
"       <tr id=\"rr1_1\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &lt; 5:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Short stature",
"         </span>",
"        </td>",
"       </tr>",
"       <tr id=\"rr1_2\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &gt;= 5 and &lt; 95:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Normal stature",
"         </span>",
"        </td>",
"       </tr>",
"       <tr id=\"rr1_3\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &gt;= 95:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Tall stature",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOne\">",
"      In some cases, including consideration of pharmacotherapy, more stringent definitions of short or tall stature are",
"used, with thresholds of &lt; 3rd percentile or  &lt; 1st percentile for short stature, and &gt; 97th or &gt; 99th",
"percentile for tall stature.",
"      <br/>",
"      &nbsp;",
"      <br/>",
"      At the extremes ( &gt; 97th percentile or &lt; 3rd percentile), small differences in percentiles represent  clinically important differences in height. At these extremes, the z-score is a more precise reflection  of how far the measurement deviates from the mean, and is a useful tool for tracking changes.",
"      <br/>",
"      &nbsp;",
"      <br/>",
"     </span>",
"     <span class=\"medCalcFontOneBold\">",
"      Examples",
"     </span>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <center>",
"      <table border=\"1\" cellpadding=\"3\" class=\"medCalcFontOne\" summary=\"MedCalc 3000 Table\" width=\"40%\">",
"       <tr>",
"        <td align=\"center\" bgcolor=\"#cccccc\">",
"         <b>",
"          Z-score",
"         </b>",
"        </td>",
"        <td align=\"center\" bgcolor=\"#cccccc\">",
"         <b>",
"          Percentile equivalent",
"         </b>",
"        </td>",
"       </tr>",
"       <tr>",
"        <td align=\"center\">",
"         - 3.0",
"        </td>",
"        <td align=\"center\">",
"         0.3",
"        </td>",
"       </tr>",
"       <tr>",
"        <td align=\"center\">",
"         - 2.0",
"        </td>",
"        <td align=\"center\">",
"         2.5",
"        </td>",
"       </tr>",
"       <tr>",
"        <td align=\"center\">",
"         + 2.0",
"        </td>",
"        <td align=\"center\">",
"         97.5",
"        </td>",
"       </tr>",
"       <tr>",
"        <td align=\"center\">",
"         + 3.0",
"        </td>",
"        <td align=\"center\">",
"         99.7",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Percentile conversion from Z-Score is done by table look-up in the standard Normal Table. Percentiles are provided for Z Scores between -3.09 and 3.09.  Values beyond these extremes return percentiles of 0.1 and 99.9 respectively.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        LMS Parameters for Girls: Height for Age. National health and nutrition survey (NHANES), CDC/National Center for Health Statistics.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22646=[" ",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"var currenttimeout;",
"",
"n = new Array;",
"var L = 0;",
"var M = 0;",
"var S = 0;",
"",
"n[0] = 50;",
"n[1] = 50.399;",
"n[2] = 50.798;",
"n[3] = 51.197;",
"n[4] = 51.595;",
"n[5] = 51.994;",
"n[6] = 52.392;",
"n[7] = 52.79;",
"n[8] = 53.188;",
"n[9] = 53.586;",
"n[10] = 53.983;",
"n[11] = 54.38;",
"n[12] = 54.776;",
"n[13] = 55.172;",
"n[14] = 55.567;",
"n[15] = 55.962;",
"n[16] = 56.356;",
"n[17] = 56.749;",
"n[18] = 57.142;",
"n[19] = 57.535;",
"n[20] = 57.926;",
"n[21] = 58.317;",
"n[22] = 58.706;",
"n[23] = 59.095;",
"n[24] = 59.483;",
"n[25] = 59.871;",
"n[26] = 60.257;",
"n[27] = 60.642;",
"n[28] = 61.026;",
"n[29] = 61.409;",
"n[30] = 61.791;",
"n[31] = 62.172;",
"n[32] = 62.552;",
"n[33] = 62.93;",
"n[34] = 63.307;",
"n[35] = 63.683;",
"n[36] = 64.058;",
"n[37] = 64.431;",
"n[38] = 64.803;",
"n[39] = 65.173;",
"n[40] = 65.542;",
"n[41] = 65.91;",
"n[42] = 66.276;",
"n[43] = 66.64;",
"n[44] = 67.003;",
"n[45] = 67.364;",
"n[46] = 67.724;",
"n[47] = 68.082;",
"n[48] = 68.439;",
"n[49] = 68.793;",
"n[50] = 69.146;",
"n[51] = 69.497;",
"n[52] = 69.847;",
"n[53] = 70.194;",
"n[54] = 70.54;",
"n[55] = 70.884;",
"n[56] = 71.226;",
"n[57] = 71.566;",
"n[58] = 71.904;",
"n[59] = 72.24;",
"n[60] = 72.575;",
"n[61] = 72.907;",
"n[62] = 73.237;",
"n[63] = 73.565;",
"n[64] = 73.891;",
"n[65] = 74.215;",
"n[66] = 74.537;",
"n[67] = 74.857;",
"n[68] = 75.175;",
"n[69] = 75.49;",
"n[70] = 75.804;",
"n[71] = 76.115;",
"n[72] = 76.424;",
"n[73] = 76.73;",
"n[74] = 77.035;",
"n[75] = 77.337;",
"n[76] = 77.637;",
"n[77] = 77.935;",
"n[78] = 78.23;",
"n[79] = 78.524;",
"n[80] = 78.814;",
"n[81] = 79.103;",
"n[82] = 79.389;",
"n[83] = 79.673;",
"n[84] = 79.955;",
"n[85] = 80.234;",
"n[86] = 80.511;",
"n[87] = 80.785;",
"n[88] = 81.057;",
"n[89] = 81.327;",
"n[90] = 81.594;",
"n[91] = 81.859;",
"n[92] = 82.121;",
"n[93] = 82.381;",
"n[94] = 82.639;",
"n[95] = 82.894;",
"n[96] = 83.147;",
"n[97] = 83.398;",
"n[98] = 83.646;",
"n[99] = 83.891;",
"n[100] = 84.134;",
"n[101] = 84.375;",
"n[102] = 84.614;",
"n[103] = 84.849;",
"n[104] = 85.083;",
"n[105] = 85.314;",
"n[106] = 85.543;",
"n[107] = 85.769;",
"n[108] = 85.993;",
"n[109] = 86.214;",
"n[110] = 86.433;",
"n[111] = 86.65;",
"n[112] = 86.864;",
"n[113] = 87.076;",
"n[114] = 87.286;",
"n[115] = 87.493;",
"n[116] = 87.698;",
"n[117] = 87.9;",
"n[118] = 88.1;",
"n[119] = 88.298;",
"n[120] = 88.493;",
"n[121] = 88.686;",
"n[122] = 88.877;",
"n[123] = 89.065;",
"n[124] = 89.251;",
"n[125] = 89.435;",
"n[126] = 89.617;",
"n[127] = 89.796;",
"n[128] = 89.973;",
"n[129] = 90.147;",
"n[130] = 90.32;",
"n[131] = 90.49;",
"n[132] = 90.658;",
"n[133] = 90.824;",
"n[134] = 90.988;",
"n[135] = 91.149;",
"n[136] = 91.308;",
"n[137] = 91.466;",
"n[138] = 91.621;",
"n[139] = 91.774;",
"n[140] = 91.924;",
"n[141] = 92.073;",
"n[142] = 92.22;",
"n[143] = 92.364;",
"n[144] = 92.507;",
"n[145] = 92.647;",
"n[146] = 92.785;",
"n[147] = 92.922;",
"n[148] = 93.056;",
"n[149] = 93.189;",
"n[150] = 93.319;",
"n[151] = 93.448;",
"n[152] = 93.574;",
"n[153] = 93.699;",
"n[154] = 93.822;",
"n[155] = 93.943;",
"n[156] = 94.062;",
"n[157] = 94.179;",
"n[158] = 94.295;",
"n[159] = 94.408;",
"n[160] = 94.52;",
"n[161] = 94.63;",
"n[162] = 94.738;",
"n[163] = 94.845;",
"n[164] = 94.95;",
"n[165] = 95.053;",
"n[166] = 95.154;",
"n[167] = 95.254;",
"n[168] = 95.352;",
"n[169] = 95.449;",
"n[170] = 95.543;",
"n[171] = 95.637;",
"n[172] = 95.728;",
"n[173] = 95.818;",
"n[174] = 95.907;",
"n[175] = 95.994;",
"n[176] = 96.08;",
"n[177] = 96.164;",
"n[178] = 96.246;",
"n[179] = 96.327;",
"n[180] = 96.407;",
"n[181] = 96.485;",
"n[182] = 96.562;",
"n[183] = 96.638;",
"n[184] = 96.712;",
"n[185] = 96.784;",
"n[186] = 96.856;",
"n[187] = 96.926;",
"n[188] = 96.995;",
"n[189] = 97.062;",
"n[190] = 97.128;",
"n[191] = 97.193;",
"n[192] = 97.257;",
"n[193] = 97.32;",
"n[194] = 97.381;",
"n[195] = 97.441;",
"n[196] = 97.5;",
"n[197] = 97.558;",
"n[198] = 97.615;",
"n[199] = 97.67;",
"n[200] = 97.725;",
"n[201] = 97.778;",
"n[202] = 97.831;",
"n[203] = 97.882;",
"n[204] = 97.932;",
"n[205] = 97.982;",
"n[206] = 98.03;",
"n[207] = 98.077;",
"n[208] = 98.124;",
"n[209] = 98.169;",
"n[210] = 98.214;",
"n[211] = 98.257;",
"n[212] = 98.3;",
"n[213] = 98.341;",
"n[214] = 98.382;",
"n[215] = 98.422;",
"n[216] = 98.461;",
"n[217] = 98.5;",
"n[218] = 98.537;",
"n[219] = 98.574;",
"n[220] = 98.61;",
"n[221] = 98.645;",
"n[222] = 98.679;",
"n[223] = 98.713;",
"n[224] = 98.745;",
"n[225] = 98.778;",
"n[226] = 98.809;",
"n[227] = 98.84;",
"n[228] = 98.87;",
"n[229] = 98.899;",
"n[230] = 98.928;",
"n[231] = 98.956;",
"n[232] = 98.983;",
"n[233] = 99.01;",
"n[234] = 99.036;",
"n[235] = 99.061;",
"n[236] = 99.086;",
"n[237] = 99.111;",
"n[238] = 99.134;",
"n[239] = 99.158;",
"n[240] = 99.18;",
"n[241] = 99.202;",
"n[242] = 99.224;",
"n[243] = 99.245;",
"n[244] = 99.266;",
"n[245] = 99.286;",
"n[246] = 99.305;",
"n[247] = 99.324;",
"n[248] = 99.343;",
"n[249] = 99.361;",
"n[250] = 99.379;",
"n[251] = 99.396;",
"n[252] = 99.413;",
"n[253] = 99.43;",
"n[254] = 99.446;",
"n[255] = 99.461;",
"n[256] = 99.477;",
"n[257] = 99.492;",
"n[258] = 99.506;",
"n[259] = 99.52;",
"n[260] = 99.534;",
"n[261] = 99.547;",
"n[262] = 99.56;",
"n[263] = 99.573;",
"n[264] = 99.585;",
"n[265] = 99.598;",
"n[266] = 99.609;",
"n[267] = 99.621;",
"n[268] = 99.632;",
"n[269] = 99.643;",
"n[270] = 99.653;",
"n[271] = 99.664;",
"n[272] = 99.674;",
"n[273] = 99.683;",
"n[274] = 99.693;",
"n[275] = 99.702;",
"n[276] = 99.711;",
"n[277] = 99.72;",
"n[278] = 99.728;",
"n[279] = 99.736;",
"n[280] = 99.744;",
"n[281] = 99.752;",
"n[282] = 99.76;",
"n[283] = 99.767;",
"n[284] = 99.774;",
"n[285] = 99.781;",
"n[286] = 99.788;",
"n[287] = 99.795;",
"n[288] = 99.801;",
"n[289] = 99.807;",
"n[290] = 99.813;",
"n[291] = 99.819;",
"n[292] = 99.825;",
"n[293] = 99.831;",
"n[294] = 99.836;",
"n[295] = 99.841;",
"n[296] = 99.846;",
"n[297] = 99.851;",
"n[298] = 99.856;",
"n[299] = 99.861;",
"n[300] = 99.865;",
"n[301] = 99.869;",
"n[302] = 99.874;",
"n[303] = 99.878;",
"n[304] = 99.882;",
"n[305] = 99.886;",
"n[306] = 99.889;",
"n[307] = 99.893;",
"n[308] = 99.896;",
"n[309] = 99.9;",
"",
"function ZtoPercentile(z){",
"with (document.CDCHeightForAgeGirls_form){",
"az = Math.abs(z);",
"if (z < -3.09) return 0.1;",
"if (z > 3.09) return 99.9;",
"thispercentile = n[Math.round(az * 100)];",
"if (z >= 0) { return thispercentile }",
"else { return 100 - thispercentile }",
"}}",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function CDCHeightForAgeGirls_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 3000);",
"",
"with(document.CDCHeightForAgeGirls_form){",
"",
"",
"doCalc = true;",
"if (Age_param.value.indexOf(',') >= 0){ Age_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Age_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Age_unit.options[Age_unit.selectedIndex].value.split('|');",
"Age = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Height_param.value.indexOf(',') >= 0){ Height_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Height_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Height_unit.options[Height_unit.selectedIndex].value.split('|');",
"Height = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"dp = decpts.options[decpts.selectedIndex].text;",
"Age_Months =  Age * 12;",
"",
"if(Age_Months >= 24 && Age_Months < 25){L = 1.051272912; M = 85.3973169; S = 0.040859727;};",
"if(Age_Months >= 25 && Age_Months < 26){L = 1.041951175; M = 86.29026318; S = 0.041142161;};",
"if(Age_Months >= 26 && Age_Months < 27){L = 1.012592236; M = 87.15714182; S = 0.041349399;};",
"if(Age_Months >= 27 && Age_Months < 28){L = 0.970541909; M = 87.9960184; S = 0.041500428;};",
"if(Age_Months >= 28 && Age_Months < 29){L = 0.921129988; M = 88.8055115; S = 0.041610508;};",
"if(Age_Months >= 29 && Age_Months < 30){L = 0.868221392; M = 89.58476689; S = 0.041691761;};",
"if(Age_Months >= 30 && Age_Months < 31){L = 0.81454413; M = 90.33341722; S = 0.04175368;};",
"if(Age_Months >= 31 && Age_Months < 32){L = 0.761957977; M = 91.0515436; S = 0.041803562;};",
"if(Age_Months >= 32 && Age_Months < 33){L = 0.711660228; M = 91.7396352; S = 0.041846882;};",
"if(Age_Months >= 33 && Age_Months < 34){L = 0.664323379; M = 92.39854429; S = 0.041887626;};",
"if(Age_Months >= 34 && Age_Months < 35){L = 0.620285102; M = 93.02945392; S = 0.041928568;};",
"if(Age_Months >= 35 && Age_Months < 36){L = 0.57955631; M = 93.63382278; S = 0.041971514;};",
"if(Age_Months >= 36 && Age_Months < 37){L = 0.54198094; M = 94.21335709; S = 0.042017509;};",
"if(Age_Months >= 37 && Age_Months < 38){L = 0.511429832; M = 94.79643239; S = 0.042104522;};",
"if(Age_Months >= 38 && Age_Months < 39){L = 0.482799937; M = 95.37391918; S = 0.042199507;};",
"if(Age_Months >= 39 && Age_Months < 40){L = 0.455521041; M = 95.94692677; S = 0.042300333;};",
"if(Age_Months >= 40 && Age_Months < 41){L = 0.429150288; M = 96.51644912; S = 0.042405225;};",
"if(Age_Months >= 41 && Age_Months < 42){L = 0.403351725; M = 97.08337211; S = 0.042512706;};",
"if(Age_Months >= 42 && Age_Months < 43){L = 0.377878239; M = 97.6484807; S = 0.042621565;};",
"if(Age_Months >= 43 && Age_Months < 44){L = 0.352555862; M = 98.21246579; S = 0.042730809;};",
"if(Age_Months >= 44 && Age_Months < 45){L = 0.327270297; M = 98.77593069; S = 0.042839638;};",
"if(Age_Months >= 45 && Age_Months < 46){L = 0.301955463; M = 99.33939735; S = 0.042947412;};",
"if(Age_Months >= 46 && Age_Months < 47){L = 0.276583851; M = 99.9033122; S = 0.043053626;};",
"if(Age_Months >= 47 && Age_Months < 48){L = 0.251158446; M = 100.4680516; S = 0.043157889;};",
"if(Age_Months >= 48 && Age_Months < 49){L = 0.225705996; M = 101.033927; S = 0.043259907;};",
"if(Age_Months >= 49 && Age_Months < 50){L = 0.20027145; M = 101.6011898; S = 0.043359463;};",
"if(Age_Months >= 50 && Age_Months < 51){L = 0.174913356; M = 102.1700358; S = 0.043456406;};",
"if(Age_Months >= 51 && Age_Months < 52){L = 0.149700081; M = 102.7406094; S = 0.043550638;};",
"if(Age_Months >= 52 && Age_Months < 53){L = 0.12470671; M = 103.3130077; S = 0.043642107;};",
"if(Age_Months >= 53 && Age_Months < 54){L = 0.100012514; M = 103.8872839; S = 0.043730791;};",
"if(Age_Months >= 54 && Age_Months < 55){L = 0.075698881; M = 104.4634511; S = 0.043816701;};",
"if(Age_Months >= 55 && Age_Months < 56){L = 0.051847635; M = 105.0414853; S = 0.043899867;};",
"if(Age_Months >= 56 && Age_Months < 57){L = 0.02853967; M = 105.6213287; S = 0.043980337;};",
"if(Age_Months >= 57 && Age_Months < 58){L = 0.005853853; M = 106.2028921; S = 0.044058171;};",
"if(Age_Months >= 58 && Age_Months < 59){L = -0.016133871; M = 106.7860583; S = 0.04413344;};",
"if(Age_Months >= 59 && Age_Months < 60){L = -0.037351181; M = 107.3706841; S = 0.044206218;};",
"if(Age_Months >= 60 && Age_Months < 61){L = -0.057729947; M = 107.9566031; S = 0.044276588;};",
"if(Age_Months >= 61 && Age_Months < 62){L = -0.077206672; M = 108.5436278; S = 0.044344632;};",
"if(Age_Months >= 62 && Age_Months < 63){L = -0.09572283; M = 109.1315521; S = 0.044410436;};",
"if(Age_Months >= 63 && Age_Months < 64){L = -0.113225128; M = 109.7201531; S = 0.044474084;};",
"if(Age_Months >= 64 && Age_Months < 65){L = -0.129665689; M = 110.3091934; S = 0.044535662;};",
"if(Age_Months >= 65 && Age_Months < 66){L = -0.145002179; M = 110.8984228; S = 0.044595254;};",
"if(Age_Months >= 66 && Age_Months < 67){L = -0.159197885; M = 111.4875806; S = 0.044652942;};",
"if(Age_Months >= 67 && Age_Months < 68){L = -0.172221748; M = 112.0763967; S = 0.044708809;};",
"if(Age_Months >= 68 && Age_Months < 69){L = -0.184048358; M = 112.6645943; S = 0.044762936;};",
"if(Age_Months >= 69 && Age_Months < 70){L = -0.194660215; M = 113.2518902; S = 0.044815402;};",
"if(Age_Months >= 70 && Age_Months < 71){L = -0.204030559; M = 113.8380006; S = 0.044866288;};",
"if(Age_Months >= 71 && Age_Months < 72){L = -0.212174408; M = 114.4226317; S = 0.044915672;};",
"if(Age_Months >= 72 && Age_Months < 73){L = -0.219069129; M = 115.0054978; S = 0.044963636;};",
"if(Age_Months >= 73 && Age_Months < 74){L = -0.224722166; M = 115.5863089; S = 0.045010259;};",
"if(Age_Months >= 74 && Age_Months < 75){L = -0.229140412; M = 116.1647782; S = 0.045055624;};",
"if(Age_Months >= 75 && Age_Months < 76){L = -0.232335686; M = 116.7406221; S = 0.045099817;};",
"if(Age_Months >= 76 && Age_Months < 77){L = -0.234324563; M = 117.3135622; S = 0.045142924;};",
"if(Age_Months >= 77 && Age_Months < 78){L = -0.235128195; M = 117.8833259; S = 0.045185036;};",
"if(Age_Months >= 78 && Age_Months < 79){L = -0.234772114; M = 118.4496481; S = 0.045226249;};",
"if(Age_Months >= 79 && Age_Months < 80){L = -0.233286033; M = 119.0122722; S = 0.045266662;};",
"if(Age_Months >= 80 && Age_Months < 81){L = -0.230703633; M = 119.5709513; S = 0.045306383;};",
"if(Age_Months >= 81 && Age_Months < 82){L = -0.227062344; M = 120.1254495; S = 0.045345524;};",
"if(Age_Months >= 82 && Age_Months < 83){L = -0.222403111; M = 120.6755427; S = 0.045384203;};",
"if(Age_Months >= 83 && Age_Months < 84){L = -0.216770161; M = 121.22102; S = 0.045422551;};",
"if(Age_Months >= 84 && Age_Months < 85){L = -0.210210748; M = 121.7616844; S = 0.045460702;};",
"if(Age_Months >= 85 && Age_Months < 86){L = -0.202774891; M = 122.2973542; S = 0.045498803;};",
"if(Age_Months >= 86 && Age_Months < 87){L = -0.194515104; M = 122.827864; S = 0.045537012;};",
"if(Age_Months >= 87 && Age_Months < 88){L = -0.185486099; M = 123.3530652; S = 0.045575495;};",
"if(Age_Months >= 88 && Age_Months < 89){L = -0.175744476; M = 123.8728276; S = 0.045614432;};",
"if(Age_Months >= 89 && Age_Months < 90){L = -0.165348396; M = 124.38704; S = 0.045654016;};",
"if(Age_Months >= 90 && Age_Months < 91){L = -0.15435722; M = 124.8956114; S = 0.04569445;};",
"if(Age_Months >= 91 && Age_Months < 92){L = -0.142831123; M = 125.398472; S = 0.045735953;};",
"if(Age_Months >= 92 && Age_Months < 93){L = -0.130830669; M = 125.895574; S = 0.045778759;};",
"if(Age_Months >= 93 && Age_Months < 94){L = -0.118416354; M = 126.3868929; S = 0.045823114;};",
"if(Age_Months >= 94 && Age_Months < 95){L = -0.105648092; M = 126.8724284; S = 0.04586928;};",
"if(Age_Months >= 95 && Age_Months < 96){L = -0.092584657; M = 127.3522056; S = 0.045917535;};",
"if(Age_Months >= 96 && Age_Months < 97){L = -0.079283065; M = 127.8262759; S = 0.045968169;};",
"if(Age_Months >= 97 && Age_Months < 98){L = -0.065797888; M = 128.2947187; S = 0.04602149;};",
"if(Age_Months >= 98 && Age_Months < 99){L = -0.0521805; M = 128.757642; S = 0.046077818;};",
"if(Age_Months >= 99 && Age_Months < 100){L = -0.03847825; M = 129.2151839; S = 0.046137487;};",
"if(Age_Months >= 100 && Age_Months < 101){L = -0.024733545; M = 129.6675143; S = 0.046200842;};",
"if(Age_Months >= 101 && Age_Months < 102){L = -0.010982868; M = 130.1148354; S = 0.04626824;};",
"if(Age_Months >= 102 && Age_Months < 103){L = 0.002744306; M = 130.5573839; S = 0.046340046;};",
"if(Age_Months >= 103 && Age_Months < 104){L = 0.016426655; M = 130.995432; S = 0.046416629;};",
"if(Age_Months >= 104 && Age_Months < 105){L = 0.030052231; M = 131.4292887; S = 0.046498361;};",
"if(Age_Months >= 105 && Age_Months < 106){L = 0.043619747; M = 131.8593015; S = 0.046585611;};",
"if(Age_Months >= 106 && Age_Months < 107){L = 0.05713988; M = 132.2858574; S = 0.046678741;};",
"if(Age_Months >= 107 && Age_Months < 108){L = 0.070636605; M = 132.7093845; S = 0.046778099;};",
"if(Age_Months >= 108 && Age_Months < 109){L = 0.08414848; M = 133.1303527; S = 0.04688401;};",
"if(Age_Months >= 109 && Age_Months < 110){L = 0.097729873; M = 133.5492749; S = 0.046996769;};",
"if(Age_Months >= 110 && Age_Months < 111){L = 0.111452039; M = 133.9667073; S = 0.047116633;};",
"if(Age_Months >= 111 && Age_Months < 112){L = 0.125404005; M = 134.3832499; S = 0.047243801;};",
"if(Age_Months >= 112 && Age_Months < 113){L = 0.13969316; M = 134.7995463; S = 0.047378413;};",
"if(Age_Months >= 113 && Age_Months < 114){L = 0.154445482; M = 135.2162826; S = 0.047520521;};",
"if(Age_Months >= 114 && Age_Months < 115){L = 0.169805275; M = 135.634186; S = 0.047670085;};",
"if(Age_Months >= 115 && Age_Months < 116){L = 0.185934346; M = 136.0540223; S = 0.047826946;};",
"if(Age_Months >= 116 && Age_Months < 117){L = 0.203010488; M = 136.4765925; S = 0.04799081;};",
"if(Age_Months >= 117 && Age_Months < 118){L = 0.2212252; M = 136.9027281; S = 0.048161228;};",
"if(Age_Months >= 118 && Age_Months < 119){L = 0.240780542; M = 137.3332846; S = 0.04833757;};",
"if(Age_Months >= 119 && Age_Months < 120){L = 0.261885086; M = 137.7691339; S = 0.048519011;};",
"if(Age_Months >= 120 && Age_Months < 121){L = 0.284748919; M = 138.2111552; S = 0.048704503;};",
"if(Age_Months >= 121 && Age_Months < 122){L = 0.309577733; M = 138.6602228; S = 0.048892759;};",
"if(Age_Months >= 122 && Age_Months < 123){L = 0.336566048; M = 139.1171933; S = 0.049082239;};",
"if(Age_Months >= 123 && Age_Months < 124){L = 0.365889711; M = 139.5828898; S = 0.049271137;};",
"if(Age_Months >= 124 && Age_Months < 125){L = 0.397699038; M = 140.0580848; S = 0.049457371;};",
"if(Age_Months >= 125 && Age_Months < 126){L = 0.432104409; M = 140.5434787; S = 0.049638596;};",
"if(Age_Months >= 126 && Age_Months < 127){L = 0.46917993; M = 141.0396832; S = 0.049812203;};",
"if(Age_Months >= 127 && Age_Months < 128){L = 0.508943272; M = 141.5471945; S = 0.049975355;};",
"if(Age_Months >= 128 && Age_Months < 129){L = 0.551354277; M = 142.0663731; S = 0.050125012;};",
"if(Age_Months >= 129 && Age_Months < 130){L = 0.596307363; M = 142.59742; S = 0.050257992;};",
"if(Age_Months >= 130 && Age_Months < 131){L = 0.643626542; M = 143.1403553; S = 0.050371024;};",
"if(Age_Months >= 131 && Age_Months < 132){L = 0.693062173; M = 143.6949981; S = 0.050460835;};",
"if(Age_Months >= 132 && Age_Months < 133){L = 0.744289752; M = 144.2609497; S = 0.050524236;};",
"if(Age_Months >= 133 && Age_Months < 134){L = 0.79691098; M = 144.8375809; S = 0.050558224;};",
"if(Age_Months >= 134 && Age_Months < 135){L = 0.85045728; M = 145.4240246; S = 0.050560083;};",
"if(Age_Months >= 135 && Age_Months < 136){L = 0.904395871; M = 146.0191748; S = 0.050527494;};",
"if(Age_Months >= 136 && Age_Months < 137){L = 0.958138449; M = 146.621692; S = 0.050458634;};",
"if(Age_Months >= 137 && Age_Months < 138){L = 1.011054559; M = 147.2300177; S = 0.050352269;};",
"if(Age_Months >= 138 && Age_Months < 139){L = 1.062474568; M = 147.8423918; S = 0.050207825;};",
"if(Age_Months >= 139 && Age_Months < 140){L = 1.111727029; M = 148.4568879; S = 0.050025434;};",
"if(Age_Months >= 140 && Age_Months < 141){L = 1.158135105; M = 149.0714413; S = 0.049805967;};",
"if(Age_Months >= 141 && Age_Months < 142){L = 1.201050821; M = 149.6838943; S = 0.049551023;};",
"if(Age_Months >= 142 && Age_Months < 143){L = 1.239852328; M = 150.2920328; S = 0.049262895;};",
"if(Age_Months >= 143 && Age_Months < 144){L = 1.274006058; M = 150.8936469; S = 0.048944504;};",
"if(Age_Months >= 144 && Age_Months < 145){L = 1.303044695; M = 151.4865636; S = 0.048599314;};",
"if(Age_Months >= 145 && Age_Months < 146){L = 1.326605954; M = 152.0686985; S = 0.048231224;};",
"if(Age_Months >= 146 && Age_Months < 147){L = 1.344443447; M = 152.6380955; S = 0.047844442;};",
"if(Age_Months >= 147 && Age_Months < 148){L = 1.356437773; M = 153.1929631; S = 0.047443362;};",
"if(Age_Months >= 148 && Age_Months < 149){L = 1.362602695; M = 153.7317031; S = 0.04703243;};",
"if(Age_Months >= 149 && Age_Months < 150){L = 1.363085725; M = 154.2529332; S = 0.046616026;};",
"if(Age_Months >= 150 && Age_Months < 151){L = 1.358162799; M = 154.755501; S = 0.046198356;};",
"if(Age_Months >= 151 && Age_Months < 152){L = 1.348227142; M = 155.2384904; S = 0.04578335;};",
"if(Age_Months >= 152 && Age_Months < 153){L = 1.333772923; M = 155.7012216; S = 0.045374597;};",
"if(Age_Months >= 153 && Age_Months < 154){L = 1.315374704; M = 156.1432438; S = 0.044975281;};",
"if(Age_Months >= 154 && Age_Months < 155){L = 1.293664024; M = 156.564323; S = 0.044588148;};",
"if(Age_Months >= 155 && Age_Months < 156){L = 1.269304678; M = 156.9644258; S = 0.044215488;};",
"if(Age_Months >= 156 && Age_Months < 157){L = 1.242968236; M = 157.3436995; S = 0.043859135;};",
"if(Age_Months >= 157 && Age_Months < 158){L = 1.21531127; M = 157.7024507; S = 0.04352048;};",
"if(Age_Months >= 158 && Age_Months < 159){L = 1.186955477; M = 158.0411233; S = 0.043200497;};",
"if(Age_Months >= 159 && Age_Months < 160){L = 1.158471522; M = 158.3602756; S = 0.042899776;};",
"if(Age_Months >= 160 && Age_Months < 161){L = 1.130367088; M = 158.6605588; S = 0.042618565;};",
"if(Age_Months >= 161 && Age_Months < 162){L = 1.103079209; M = 158.9426964; S = 0.042356812;};",
"if(Age_Months >= 162 && Age_Months < 163){L = 1.076970655; M = 159.2074654; S = 0.042114211;};",
"if(Age_Months >= 163 && Age_Months < 164){L = 1.052329922; M = 159.455679; S = 0.041890247;};",
"if(Age_Months >= 164 && Age_Months < 165){L = 1.029374161; M = 159.688172; S = 0.04168424;};",
"if(Age_Months >= 165 && Age_Months < 166){L = 1.008254396; M = 159.9057871; S = 0.041495379;};",
"if(Age_Months >= 166 && Age_Months < 167){L = 0.989062282; M = 160.1093647; S = 0.041322765;};",
"if(Age_Months >= 167 && Age_Months < 168){L = 0.971837799; M = 160.299733; S = 0.041165437;};",
"if(Age_Months >= 168 && Age_Months < 169){L = 0.95657215; M = 160.4776996; S = 0.041022401;};",
"if(Age_Months >= 169 && Age_Months < 170){L = 0.94324228; M = 160.6440526; S = 0.040892651;};",
"if(Age_Months >= 170 && Age_Months < 171){L = 0.931767062; M = 160.7995428; S = 0.040775193;};",
"if(Age_Months >= 171 && Age_Months < 172){L = 0.922058291; M = 160.9448916; S = 0.040669052;};",
"if(Age_Months >= 172 && Age_Months < 173){L = 0.914012643; M = 161.0807857; S = 0.040573288;};",
"if(Age_Months >= 173 && Age_Months < 174){L = 0.907516917; M = 161.2078755; S = 0.040487005;};",
"if(Age_Months >= 174 && Age_Months < 175){L = 0.902452436; M = 161.3267744; S = 0.040409354;};",
"if(Age_Months >= 175 && Age_Months < 176){L = 0.898698641; M = 161.4380593; S = 0.040339537;};",
"if(Age_Months >= 176 && Age_Months < 177){L = 0.896143482; M = 161.5422726; S = 0.040276811;};",
"if(Age_Months >= 177 && Age_Months < 178){L = 0.894659668; M = 161.639917; S = 0.040220488;};",
"if(Age_Months >= 178 && Age_Months < 179){L = 0.89413892; M = 161.7314645; S = 0.040169932;};",
"if(Age_Months >= 179 && Age_Months < 180){L = 0.894475371; M = 161.8173534; S = 0.040124562;};",
"if(Age_Months >= 180 && Age_Months < 181){L = 0.895569834; M = 161.8979913; S = 0.040083845;};",
"if(Age_Months >= 181 && Age_Months < 182){L = 0.897330209; M = 161.9737558; S = 0.040047295;};",
"if(Age_Months >= 182 && Age_Months < 183){L = 0.899671635; M = 162.0449969; S = 0.040014473;};",
"if(Age_Months >= 183 && Age_Months < 184){L = 0.902516442; M = 162.1120386; S = 0.03998498;};",
"if(Age_Months >= 184 && Age_Months < 185){L = 0.905793969; M = 162.17518; S = 0.039958458;};",
"if(Age_Months >= 185 && Age_Months < 186){L = 0.909440266; M = 162.2346979; S = 0.039934584;};",
"if(Age_Months >= 186 && Age_Months < 187){L = 0.913397733; M = 162.2908474; S = 0.039913066;};",
"if(Age_Months >= 187 && Age_Months < 188){L = 0.91761471; M = 162.343864; S = 0.039893644;};",
"if(Age_Months >= 188 && Age_Months < 189){L = 0.922045055; M = 162.3939652; S = 0.039876087;};",
"if(Age_Months >= 189 && Age_Months < 190){L = 0.926647697; M = 162.4413513; S = 0.039860185;};",
"if(Age_Months >= 190 && Age_Months < 191){L = 0.931386217; M = 162.4862071; S = 0.039845754;};",
"if(Age_Months >= 191 && Age_Months < 192){L = 0.93622842; M = 162.5287029; S = 0.039832629;};",
"if(Age_Months >= 192 && Age_Months < 193){L = 0.941145943; M = 162.5689958; S = 0.039820663;};",
"if(Age_Months >= 193 && Age_Months < 194){L = 0.94611388; M = 162.6072309; S = 0.039809725;};",
"if(Age_Months >= 194 && Age_Months < 195){L = 0.95111043; M = 162.6435418; S = 0.0397997;};",
"if(Age_Months >= 195 && Age_Months < 196){L = 0.956116576; M = 162.6780519; S = 0.039790485;};",
"if(Age_Months >= 196 && Age_Months < 197){L = 0.961115792; M = 162.7108751; S = 0.039781991;};",
"if(Age_Months >= 197 && Age_Months < 198){L = 0.966093766; M = 162.7421168; S = 0.039774136;};",
"if(Age_Months >= 198 && Age_Months < 199){L = 0.971038162; M = 162.7718741; S = 0.03976685;};",
"if(Age_Months >= 199 && Age_Months < 200){L = 0.975938391; M = 162.8002371; S = 0.03976007;};",
"if(Age_Months >= 200 && Age_Months < 201){L = 0.980785418; M = 162.8272889; S = 0.039753741;};",
"if(Age_Months >= 201 && Age_Months < 202){L = 0.985571579; M = 162.8531067; S = 0.039747815;};",
"if(Age_Months >= 202 && Age_Months < 203){L = 0.99029042; M = 162.8777619; S = 0.039742249;};",
"if(Age_Months >= 203 && Age_Months < 204){L = 0.994936555; M = 162.9013208; S = 0.039737004;};",
"if(Age_Months >= 204 && Age_Months < 205){L = 0.999505539; M = 162.9238449; S = 0.039732048;};",
"if(Age_Months >= 205 && Age_Months < 206){L = 1.003993753; M = 162.9453912; S = 0.039727352;};",
"if(Age_Months >= 206 && Age_Months < 207){L = 1.0083983; M = 162.9660131; S = 0.03972289;};",
"if(Age_Months >= 207 && Age_Months < 208){L = 1.012716921; M = 162.9857599; S = 0.03971864;};",
"if(Age_Months >= 208 && Age_Months < 209){L = 1.016947912; M = 163.0046776; S = 0.039714581;};",
"if(Age_Months >= 209 && Age_Months < 210){L = 1.021090055; M = 163.0228094; S = 0.039710697;};",
"if(Age_Months >= 210 && Age_Months < 211){L = 1.025142554; M = 163.0401953; S = 0.039706971;};",
"if(Age_Months >= 211 && Age_Months < 212){L = 1.029104983; M = 163.0568727; S = 0.039703391;};",
"if(Age_Months >= 212 && Age_Months < 213){L = 1.032977233; M = 163.0728768; S = 0.039699945;};",
"if(Age_Months >= 213 && Age_Months < 214){L = 1.036759475; M = 163.0882404; S = 0.039696623;};",
"if(Age_Months >= 214 && Age_Months < 215){L = 1.040452117; M = 163.1029943; S = 0.039693415;};",
"if(Age_Months >= 215 && Age_Months < 216){L = 1.044055774; M = 163.1171673; S = 0.039690313;};",
"if(Age_Months >= 216 && Age_Months < 217){L = 1.047571238; M = 163.1307866; S = 0.039687311;};",
"if(Age_Months >= 217 && Age_Months < 218){L = 1.050999451; M = 163.1438776; S = 0.039684402;};",
"if(Age_Months >= 218 && Age_Months < 219){L = 1.054341482; M = 163.1564644; S = 0.039681581;};",
"if(Age_Months >= 219 && Age_Months < 220){L = 1.057598512; M = 163.1685697; S = 0.039678842;};",
"if(Age_Months >= 220 && Age_Months < 221){L = 1.060771808; M = 163.1802146; S = 0.039676182;};",
"if(Age_Months >= 221 && Age_Months < 222){L = 1.063862715; M = 163.1914194; S = 0.039673596;};",
"if(Age_Months >= 222 && Age_Months < 223){L = 1.066872639; M = 163.202203; S = 0.039671082;};",
"if(Age_Months >= 223 && Age_Months < 224){L = 1.069803036; M = 163.2125835; S = 0.039668635;};",
"if(Age_Months >= 224 && Age_Months < 225){L = 1.072655401; M = 163.2225779; S = 0.039666254;};",
"if(Age_Months >= 225 && Age_Months < 226){L = 1.075431258; M = 163.2322024; S = 0.039663936;};",
"if(Age_Months >= 226 && Age_Months < 227){L = 1.078132156; M = 163.2414722; S = 0.039661679;};",
"if(Age_Months >= 227 && Age_Months < 228){L = 1.080759655; M = 163.2504019; S = 0.039659481;};",
"if(Age_Months >= 228 && Age_Months < 229){L = 1.083315329; M = 163.2590052; S = 0.039657339;};",
"if(Age_Months >= 229 && Age_Months < 230){L = 1.085800751; M = 163.2672954; S = 0.039655252;};",
"if(Age_Months >= 230 && Age_Months < 231){L = 1.088217496; M = 163.2752848; S = 0.039653218;};",
"if(Age_Months >= 231 && Age_Months < 232){L = 1.090567133; M = 163.2829854; S = 0.039651237;};",
"if(Age_Months >= 232 && Age_Months < 233){L = 1.092851222; M = 163.2904086; S = 0.039649306;};",
"if(Age_Months >= 233 && Age_Months < 234){L = 1.095071313; M = 163.297565; S = 0.039647424;};",
"if(Age_Months >= 234 && Age_Months < 235){L = 1.097228939; M = 163.304465; S = 0.039645591;};",
"if(Age_Months >= 235 && Age_Months < 236){L = 1.099325619; M = 163.3111185; S = 0.039643804;};",
"if(Age_Months >= 236 && Age_Months < 237){L = 1.101362852; M = 163.3175349; S = 0.039642063;};",
"if(Age_Months >= 237 && Age_Months < 238){L = 1.103342119; M = 163.3237231; S = 0.039640367;};",
"if(Age_Months >= 238 && Age_Months < 239){L = 1.105264876; M = 163.3296918; S = 0.039638715;};",
"if(Age_Months >= 239 && Age_Months < 240){L = 1.107132561; M = 163.3354491; S = 0.039637105;};",
"Z_Score =  (power((Height / M), L) - 1) / (L * S);",
"",
"if (doCalc) Z_Score_param.value = fixDP(Z_Score, dp);",
"",
"",
"",
"Percentile =  ZtoPercentile(Z_Score);",
"",
"if (doCalc) Percentile_param.value = fixDP(Percentile, dp);",
"",
"",
"",
"",
"if (doCalc){",
"",
"rrclr();",
"if (Percentile < 5){ document.getElementById('rr1_1').bgColor = \"#cccccc\";",
"}",
"if ((Percentile >= 5) && (Percentile < 95)){ document.getElementById('rr1_2').bgColor = \"#cccccc\";",
"}",
"if (Percentile >= 95){ document.getElementById('rr1_3').bgColor = \"#cccccc\";",
"}",
"",
"",
"",
"}",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.CDCHeightForAgeGirls_form){",
"",
"if (Age_param.value && Age < 2) {",
"Age = 0;",
"Age_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Age is 2 yr.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Age_param.value && Age > 19.99) {",
"Age_param.value = \"\";",
"clrResults();",
"Age = 0;",
"doCalc = false;",
"alert(\"The maximum value for Age is 19.99 yr.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Height_param.value && Height < 20) {",
"Height = 0;",
"Height_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Height is 20 cm.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Height_param.value && Height > 300) {",
"Height_param.value = \"\";",
"clrResults();",
"Height = 0;",
"doCalc = false;",
"alert(\"The maximum value for Height is 300 cm.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.CDCHeightForAgeGirls_form){",
"",
"Z_Score_param.value = '';",
"Percentile_param.value = '';",
"",
"rrclr();",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"function rrclr(){",
"document.getElementById('rr1_1').bgColor = \"\";",
"document.getElementById('rr1_2').bgColor = \"\";",
"document.getElementById('rr1_3').bgColor = \"\";",
"}",
"",
"",
""].join("\n");
var outline_f22_7_22646=null;
var title_f22_7_22647="Prevention of ovarian hyperstimulation syndrome";
var content_f22_7_22647=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prevention of ovarian hyperstimulation syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/7/22647/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/7/22647/contributors\">",
"     Vaclav Insler, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/7/22647/contributors\">",
"     Bruno Lunenfeld, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/7/22647/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/7/22647/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/7/22647/contributors\">",
"     William F Crowley, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/7/22647/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/7/22647/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/7/22647/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 18, 2008.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ovarian hyperstimulation syndrome (OHSS) refers to a combination of ovarian enlargement due to multiple ovarian cysts and an acute fluid shift out of the intravascular space. The ovarian cysts are the result of multifollicular development. The most severe manifestations of the syndrome include massive ovarian enlargement from multiple cysts and, due to fluid movement out of the intravascular space, hemoconcentration and third-space accumulation of fluid; these changes may be complicated by renal failure, hypovolemic shock, thromboembolic episodes, acute respiratory distress syndrome, and death [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevention of OHSS will be reviewed here. The pathogenesis, classification, and treatment of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/41/35479?source=see_link\">",
"     \"Classification and treatment of ovarian hyperstimulation syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/17/16660?source=see_link\">",
"     \"Pathogenesis of ovarian hyperstimulation syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;An analysis of several large series encompassing 11,342 treatment cycles showed that the incidence of moderate and severe OHSS was 3.4 and 0.8 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/2\">",
"     2",
"    </a>",
"    ]. However, these data were based on reports describing ovulation induction therapy instituted prior to the introduction of combined",
"    <span class=\"nowrap\">",
"     estradiol/sonographic",
"    </span>",
"    monitoring.",
"   </p>",
"   <p>",
"    Knowledge of the risk factors for OHSS is useful for preventing the occurrence, or at least reducing the incidence of severe hyperstimulation. Factors that should be considered include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Young age and diagnosis",
"     </li>",
"     <li>",
"      High serum estradiol concentrations immediately prior to human chorionic gonadotropin (hCG) administration",
"     </li>",
"     <li>",
"      Transvaginal ultrasound examination findings (women with polycystic ovary morphology tend to have the most exuberant response to exogenous gonadotropins) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Young oligomenorrheic anovulatory women (ie, those with polycystic ovary syndrome) are at highest risk for ovarian hyperstimulation (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39495?source=see_link\">",
"     \"Diagnosis of polycystic ovary syndrome in adults\"",
"    </a>",
"    ). Increased age is associated with a decrease in the risk of OHSS [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/1\">",
"     1",
"    </a>",
"    ], but probably with a higher risk for thromboembolic complications and a lower chance of success (pregnancy). The diminished follicular and perhaps growth hormone reserve in older women may contribute to the lower risk for OHSS [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Amenorrheic women who respond to progestational agents with withdrawal bleeding, are at greater risk than hypoestrogenic amenorrheic women and should be treated more conservatively and monitored more closely. One study found that in hypoestrogenic amenorrheic women, hyperstimulation sometimes occurred in the first treatment cycle and was usually successfully avoided in subsequent cycles [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/5\">",
"     5",
"    </a>",
"    ]. On the other hand, spontaneously menstruating women often have a variable response to gonadotropin therapy, making it difficult to predict the follicle stimulating hormone (FSH) dose required for stimulation based upon previous treatment cycles (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=see_link\">",
"     \"Overview of ovulation induction\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of mutations that are associated with OHSS, both spontaneous and iatrogenic have been identified. Most of these are in the FSH receptor. This topic is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/17/16660?source=see_link\">",
"     \"Pathogenesis of ovarian hyperstimulation syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ROLE OF TREATMENT REGIMENS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence or severity of OHSS is also related to treatment schedule and to the dose of FSH and hCG. Administration of FSH according to an individually adjusted treatment regimen (with stepwise increasing or decreasing daily doses) is associated with a lower incidence of OHSS than with a fixed regimen (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=see_link\">",
"     \"Overview of ovulation induction\"",
"    </a>",
"    ). In addition, delayed administration of hCG (\"coasting\") appears to lower the risk of OHSS (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Coasting'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Gonadotropin dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are conflicting data on the importance of gonadotropin dose in the development of OHSS. In one report, gonadotropin doses correlated with OHSS severity as indicated by ovarian size and severity of ascites and pleural effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/6\">",
"     6",
"    </a>",
"    ]. In contrast, a study of 27 anovulatory women who had experienced at least one episode of hyperstimulation during human menopausal gonadotropin",
"    <span class=\"nowrap\">",
"     (hMG)/hCG",
"    </span>",
"    therapy suggested that there was no such correlation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/5\">",
"     5",
"    </a>",
"    ]. There was also no significant difference in the duration of treatment between non-hyperstimulated and hyperstimulated cycles.",
"   </p>",
"   <p>",
"    It is possible that the variability of response is of greater significance than the variability of dosage, particularly in women of WHO group II, which includes those with polycystic ovary syndrome (PCOS).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Ovulatory trigger",
"    </span>",
"    &nbsp;&mdash;&nbsp;Modern monitoring techniques (serum estradiol and transvaginal ultrasound) are important for determining gonadotropin dose adjustments, but it is unlikely that they will entirely eliminate hyperstimulation. Three types of ovulatory triggers have been evaluated: exogenous hCG, gonadotropin-releasing hormone agonists, and recombinant human luteinizing hormone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Exogenous hCG",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exogenous hCG, which mimics an ovulatory luteinizing hormone (LH) surge, also contributes to hyperstimulation risk due to the pharmacologic doses that are used, as well as its prolonged biologic half-life. This was illustrated in a study of 34 patients undergoing ovarian stimulation in an in vitro fertilization (IVF) program; serum hCG levels were detectable up to 14 days after intramuscular injection of exogenous hCG [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/7\">",
"     7",
"    </a>",
"    ]. The disappearance rate measured 36 hours after injection of hCG was exponential with a mean half-life of 2.32 days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     GnRH agonist",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to exogenous hCG, a more attenuated and shorter midcycle gonadotropin surge can be achieved by stimulating pituitary LH secretion with potent gonadotropin-releasing hormone (GnRH) agonists [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/8-11\">",
"     8-11",
"    </a>",
"    ]. The GnRH agonists are capable of evoking an LH surge sufficient for inducing ovulation, but, in general, not long enough to provoke ovarian hyperstimulation. However, some risk of ovarian hyperstimulation remains, as illustrated in a report of 48 cycles of ovarian stimulation with hMG followed by an ovulatory trigger using a nasal application of GnRH agonists, where moderate OHSS was observed in three instances [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It appears that the final follicular maturation and ovulation achieved with GnRH agonist is similar to that seen with hCG [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. However, a follicular fluid study suggests that corpus luteum function following GnRH agonist-induced ovulation may be inadequate to sustain nidation and continuation of pregnancy, and therefore pharmacologic luteal support should be given [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A potential strategy for minimizing ovarian hyperstimulation risk is a protocol combining induction of follicular development with recombinant FSH, suppression of endogenous LH with a GnRH antagonist, and GnRH agonist as the ovulatory trigger during IVF cycles [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/16\">",
"     16",
"    </a>",
"    ]. In a meta-analysis of 23 studies in 275 subjects comparing this protocol to a standard gonadotropin plus hCG protocol oocyte number was similar to that achieved with hCG. No ovarian hyperstimulation occurred in either group. However, clinical pregnancy rate was lower in the GnRH agonist group. A larger study is likely needed to see differences in hyperstimulation rates.",
"   </p>",
"   <p>",
"    The authors of this topic review use the following approach to ovarian stimulation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If on the last day of ovarian stimulation the total number of follicles in both ovaries does not exceed 10, ovulation can be triggered by hCG.",
"     </li>",
"     <li>",
"      If on the last day of ovarian stimulation the total number of follicles in both ovaries is between 10 and 20, ovulation should be triggered by GnRH agonists (0.5 mg of a short-acting preparation). This variant requires a stronger luteal support since the LH peak evoked by GnRH agonists may not be high enough or long enough to ensure implantation.",
"     </li>",
"     <li>",
"      If on the last day of ovarian stimulation the total number of follicles in both ovaries exceeds 20, ovulation should be triggered by GnRH agonists, all ova should be harvested, all available pre-embryo should be frozen and, therefore, luteal support is not required. The frozen pre-embryo may be replaced in successive cycles.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Recombinant hLH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another prevention strategy is administration of recombinant human LH (rhLH) as the ovulatory trigger rather than hCG. Since this preparation has a biologic half-life of approximately 10 hours, which is significantly shorter than that of hCG, treatment protocols creating a shorter and or lower LH peak have been designed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/17\">",
"     17",
"    </a>",
"    ]. In a double blind trial of 289 women undergoing ovarian stimulation for IVF, 12 percent of women receiving a standard dose of hCG developed moderate or severe OHSS, while there were no episodes of OHSS in those receiving a single dose of up to 30,000 IU of rhLH [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MONITORING WITH SERUM ESTRADIOL AND TVUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both serum estradiol and ultrasound monitoring are necessary when monitoring exogenous gonadotropin cycles. The pattern of estradiol rise, reflecting follicular development, is a useful parameter for monitoring gonadotropin treatment. A steep increase in serum estradiol (ie, a doubling on consecutive days) should be regarded as an important warning sign for OHSS [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The profile of the estradiol response reflects follicular development and function, while ultrasound provides information on the number and size of follicles. Rising concentrations of serum estradiol may reflect the presence of one or two mature follicles, or a large number of intermediate size follicles.",
"   </p>",
"   <p>",
"    Although OHSS generally occurs in patients with serum estradiol concentrations greater than 1500",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (&gt;6000",
"    <span class=\"nowrap\">",
"     pmol/L),",
"    </span>",
"    it has occasionally been seen with lower estradiol concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/2\">",
"     2",
"    </a>",
"    ]. This suggests that in some cases the number and size of follicles might be a better predictor of OHSS, although this has not been proven.",
"   </p>",
"   <p>",
"    In our experience, the number of nondominant follicles (9 to 15 mm) is another important predictor of OHSS. This was illustrated in a study of 44 cycles of exogenous gonadotropin therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/20\">",
"     20",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The administration of hCG (usually given when the dominant follicle is &gt;17 to 18 mm) never resulted in OHSS when there was one dominant and fewer than four nondominant follicles [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/20\">",
"       20",
"      </a>",
"      ]. In contrast, the presence of more than four follicles of 14 to 16 mm in diameter significantly correlated with the occurrence of OHSS.",
"     </li>",
"     <li>",
"      Women without hyperstimulation had the lowest total number of follicles in the preovulatory period (less than six) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The severity of hyperstimulation varied with percent increase in the number of preovulatory follicles: 38 percent in mild hyperstimulation versus 76 percent (9.6 follicles) in moderate or severe hyperstimulation.",
"     </li>",
"     <li>",
"      The distribution of the follicular categories &mdash; small, intermediate, and large (&lt;9 mm, 9 to 15 mm, and &gt;15 mm, respectively) &mdash; on the day of hCG administration predicted the severity of OHSS. Women in whom hyperstimulation did not develop showed a near equal distribution of all three follicular groups. In comparison, mild OHSS was characterized by a significantly increased number of intermediate sized follicles (69 percent) while, in severe hyperstimulation, 54 percent of the follicles were less than 9 mm in diameter. Thus, a decrease in the fraction of the mature follicles and an increase in the fraction of the small functioning follicles correlated with a higher risk of developing severe OHSS.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;All women undergoing ovarian stimulation with exogenous gonadotropins should be monitored with both serum estradiol measurements and transvaginal ultrasonography. Both are performed on the fifth day of treatment and every two to three days thereafter until hCG administration.",
"   </p>",
"   <p>",
"    hCG may be given with a low risk of OHSS to women with estradiol levels less than 1500",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    in the presence of no more than two follicles above 17 mm and less than four smaller follicles. The regimen may be altered in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It has been recommended that hCG be withheld if the serum estradiol concentration is greater than 1500",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      (&gt;6000",
"      <span class=\"nowrap\">",
"       pmol/L)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/19\">",
"       19",
"      </a>",
"      ]. We generally adhere to this rule. In special cases, however, if there are not too many intermediate or large follicles on ultrasonography, we have given hCG when serum estradiol levels exceeded 1500",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      (&gt;6000",
"      <span class=\"nowrap\">",
"       pmol/L).",
"      </span>",
"      This approach has usually not resulted in severe hyperstimulation.",
"     </li>",
"     <li>",
"      hCG should be withheld if there are more than two follicles larger than 17 mm and more than four follicles &lt;17 mm. In certain situations, the treatment cycle might be salvaged by inducing an LH surge with GnRH agonists.",
"     </li>",
"     <li>",
"      hCG may be given and follicular reduction considered if the serum estradiol is above 1500",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      (&gt;6000",
"      <span class=\"nowrap\">",
"       pmol/L)",
"      </span>",
"      in the presence of more than two large follicles but fewer than four smaller follicles [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the large review mentioned above, only some of the women who received hCG despite an inappropriate rise or excessive levels of serum estradiol developed ovarian hyperstimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/2\">",
"     2",
"    </a>",
"    ]. However, identifying these women is difficult prospectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     OTHER PREVENTIVE STRATEGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to withholding hCG in high risk cycles, the following treatment variants may be considered for reducing the incidence",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    severity of OHSS:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Coasting [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/22-24\">",
"       22-24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Transforming",
"     </li>",
"     <li>",
"      Replacing hCG with a GnRH agonist [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/25-27\">",
"       25-27",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Replacing hCG with recombinant LH [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/17\">",
"       17",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Performing follicular reduction [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/21\">",
"       21",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Intravenous albumin [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/28-33\">",
"       28-33",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Dopamine agonist administration [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Coasting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coasting refers to delaying the administration of hCG in high risk cycles until serum estradiol falls into an acceptable range (typically less than 2500 to 3000",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/33\">",
"     33",
"    </a>",
"    ]). IVF studies suggest coasting for an average of two to six days results in a lower rate of OHSS while maintaining reasonable pregnancy rates [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/22-24,33,36,37\">",
"     22-24,33,36,37",
"    </a>",
"    ]. The impact of coasting has not been studied in non-IVF stimulated cycles. The authors of one review concluded that there is insufficient evidence to determine if coasting is effective for OHSS prevention [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Transforming to an IVF cycle",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another option is transforming the ovulation induction cycle into an IVF cycle. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37770?source=see_link\">",
"     \"In vitro fertilization\"",
"    </a>",
"    .) The embryos obtained can either be replaced in the same cycle or cryopreserved and replaced in subsequent spontaneous cycles. However, a Cochrane review of embryo cryopreservation concluded that there is inadequate evidence that cryopreservation results in a lower risk of OHSS when compared with fresh embryo transfer. In addition, no benefit of embryo cryopreservation over intravenous albumin has been demonstrated (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Intravenous albumin'",
"    </a>",
"    below)&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    GnRH agonists are used routinely in IVF protocols for pituitary desensitization. Complete desensitization can be achieved much more rapidly with GnRH antagonists [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/40\">",
"     40",
"    </a>",
"    ]. In a Cochrane review of five randomized trials, the risk of severe OHSS was significantly lower with GnRH antagonists compared to agonists (odds ratio 0.36; 95% CI 0.16-0.80) at a cost of a significant reduction in clinical pregnancies (OR 0.78, 95% CI 0.62-0.97) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Intravenous albumin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Administration of intravenous albumin (at the time of oocyte retrieval and immediately thereafter) has been studied as a possible prevention strategy, mostly in small trials [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. A meta-analysis from the Cochrane database included five trials with a total of 378 patients deemed to be at high risk for severe OHSS (eg, marked elevation in serum estradiol) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/30\">",
"     30",
"    </a>",
"    ]. The treatment regimens varied from 10 to 50 g of albumin given one or two hours before oocyte retrieval to 10 to 20 g of albumin given just after oocyte retrieval. Overall, severe OHSS developed in 14 of 185 patients treated with placebo compared with 4 of 193 given intravenous albumin (common odds ratio 0.28, 95% CI 0.11-0.73). Four of five trials showed a benefit, one did not [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/31\">",
"     31",
"    </a>",
"    ]. There was no effect of albumin therapy on conception. The authors concluded that human albumin administration proximate to oocyte retrieval reduced the risk of severe OHSS in high risk women. Absolute risk reduction was 5.5 percent and 18 women would need to be treated to prevent one case of severe OHSS.",
"   </p>",
"   <p>",
"    In contrast to the results of the meta-analysis, a large trial of 988 women undergoing IVF randomly assigned to intravenous albumin or no treatment on the day of oocyte retrieval demonstrated no beneficial effect of albumin therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/42\">",
"     42",
"    </a>",
"    ]. Thus, data on the efficacy of intravenous albumin for the prevention of OHSS are conflicting.",
"   </p>",
"   <p>",
"    The possible efficacy of hydroxyethyl starch in prevention of OHSS was reported in two prospective, randomized, placebo-controlled trials including over 350 patients; the magnitude of benefit was similar to that noted in the meta-analysis of intravenous albumin trials [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/32,43\">",
"     32,43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;One retrospective series suggested administration of methylprednisolone (16 mg starting on day six of the stimulation cycle and tapered beginning day 13 after embryo transfer) to women at high risk of developing OHSS reduced the prevalence of this disorder (10 versus 44 percent in untreated women) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/44\">",
"     44",
"    </a>",
"    ]. High risk women were defined as those with more than 20 follicles less than 10 mm in diameter and estradiol concentrations greater than 600",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    on the fifth day of the stimulation protocol. The only other series that evaluated administration of glucocorticoids to high risk patients did not find a reduction in the rate of OHSS (about 42 percent in both treated and control groups) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/45\">",
"     45",
"    </a>",
"    ]. There is insufficient data to recommend use of corticosteroid prophylaxis at this time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Dopamine agonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;The increased vascular permeability seen in OHSS is primarily due to ovarian hypersecretion of vascular endothelial growth factor (VEGF), which activates its receptor (VEGFR-2). In a rat OHSS model, administration of a dopamine agonist,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/2/7206?source=see_link\">",
"     cabergoline",
"    </a>",
"    , inactivates VEGFR-2 and prevents the increase in vascular permeability [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/17/16660?source=see_link\">",
"     \"Pathogenesis of ovarian hyperstimulation syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/2/7206?source=see_link\">",
"     Cabergoline",
"    </a>",
"    may also be effective for preventing OHSS in women. This was illustrated in a trial of 69 oocyte donors undergoing assisted reproduction who were at high risk for OHSS (&gt;20 oocytes retrieved) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22647/abstract/35\">",
"     35",
"    </a>",
"    ]. Patients were randomly assigned to receive daily cabergoline (0.5 mg) or placebo until the day of hCG administration. Cabergoline prevented the increase in vascular permeability (as measured by magnetic resonance studies), and reduced the rate of moderate OHSS (20 and 44 percent in the cabergoline and placebo groups, respectively).",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/1\">",
"      Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978; 30:255.",
"     </a>",
"    </li>",
"    <li>",
"     Lunenfeld, B, Insler, V, Glezerman, M. Diagnosis and Treatment of Functional Infertility, 3rd ed, Blackwell Wissenschaft, Berlin, 1993, p. 98.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/3\">",
"      Lass A, Vassiliev A, Decosterd G, et al. Relationship of baseline ovarian volume to ovarian response in World Health Organization II anovulatory patients who underwent ovulation induction with gonadotropins. Fertil Steril 2002; 78:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/4\">",
"      Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993; 14:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/5\">",
"      Tulandi T, McInnes RA, Arronet GH. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin. Int J Fertil 1984; 29:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/6\">",
"      Fauser BC, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 1997; 18:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/7\">",
"      Damewood MD, Shen W, Zacur HA, et al. Disappearance of exogenously administered human chorionic gonadotropin. Fertil Steril 1989; 52:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/8\">",
"      Gonen Y, Balakier H, Powell W, Casper RF. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab 1990; 71:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/9\">",
"      Emperaire JC, Ruffie A. Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome. Hum Reprod 1991; 6:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/10\">",
"      Itskovitz J, Boldes R, Levron J, et al. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril 1991; 56:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/11\">",
"      Corson SL, Batzer FR, Gocial B, Maislin G. The luteal phase after ovulation induction with human menopausal gonadotropin and one versus two doses of a gonadotropin-releasing hormone agonist. Fertil Steril 1993; 59:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/12\">",
"      van der Meer S, Gerris J, Joostens M, Tas B. Triggering of ovulation using a gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome. Hum Reprod 1993; 8:1628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/13\">",
"      Tay CC. Use of gonadotrophin-releasing hormone agonists to trigger ovulation. Hum Fertil (Camb) 2002; 5:G35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/14\">",
"      Andersen CY, Humaidan P, Ejdrup HB, et al. Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or hCG for ovulation induction. Hum Reprod 2006; 21:2126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/15\">",
"      Lanzone A, Fulghesu AM, Villa P, et al. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles. Fertil Steril 1994; 62:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/16\">",
"      Kol S, Muchtar M. Recombinant gonadotrophin-based, ovarian hyperstimulation syndrome-free stimulation of the high responder: suggested protocol for further research. Reprod Biomed Online 2005; 10:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/17\">",
"      Imthurn B, Piazzi A, Loumaye E. Recombinant human luteinising hormone to mimic mid-cycle LH surge. Lancet 1996; 348:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/18\">",
"      European Recombinant LH Study Group. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab 2001; 86:2607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/19\">",
"      Haning RV Jr, Austin CW, Carlson IH, et al. Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins. Fertil Steril 1983; 40:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/20\">",
"      Blankstein J, Shalev J, Saadon T, et al. Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Fertil Steril 1987; 47:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/21\">",
"      Tomazevic T, Meden-Vrtovec H. Early timed follicular aspiration prevents severe ovarian hyperstimulation syndrome. J Assist Reprod Genet 1996; 13:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/22\">",
"      Grochowski D, Woczyski S, Kuczyski W, et al. Correctly timed coasting reduces the risk of ovarian hyperstimulation syndrome and gives good cycle outcome in an in vitro fertilization program. Gynecol Endocrinol 2001; 15:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/23\">",
"      Sher G, Zouves C, Feinman M, Maassarani G. 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum Reprod 1995; 10:3107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/24\">",
"      Waldenstr&ouml;m U, Kahn J, Marsk L, Nilsson S. High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by 'prolonged coasting' of very hyperstimulated patients: a multicentre study. Hum Reprod 1999; 14:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/25\">",
"      Lewit N, Kol S, Manor D, Itskovitz-Eldor J. Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study. Hum Reprod 1996; 11:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/26\">",
"      Gerris J, De Vits A, Joostens M, Van Royen E. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU). Hum Reprod 1995; 10:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/27\">",
"      Shalev E, Geslevich Y, Ben-Ami M. Induction of pre-ovulatory luteinizing hormone surge by gonadotrophin-releasing hormone agonist for women at risk for developing the ovarian hyperstimulation syndrome. Hum Reprod 1994; 9:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/28\">",
"      Isik AZ, Gokmen O, Zeyneloglu HB, et al. Intravenous albumin prevents moderate-severe ovarian hyperstimulation in in-vitro fertilization patients: a prospective, randomized and controlled study. Eur J Obstet Gynecol Reprod Biol 1996; 70:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/29\">",
"      Shoham Z, Weissman A, Barash A, et al. Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study. Fertil Steril 1994; 62:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/30\">",
"      Aboulghar M, Evers JH, Al-Inany H. Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review. Hum Reprod 2002; 17:3027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/31\">",
"      Ben-Chetrit A, Eldar-Geva T, Gal M, et al. The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial. Hum Reprod 2001; 16:1880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/32\">",
"      K&ouml;nig E, Bussen S, S&uuml;tterlin M, Steck T. Prophylactic intravenous hydroxyethyle starch solution prevents moderate-severe ovarian hyperstimulation in in-vitro fertilization patients: a prospective, randomized, double-blind and placebo-controlled study. Hum Reprod 1998; 13:2421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/33\">",
"      Levinsohn-Tavor O, Friedler S, Schachter M, et al. Coasting-what is the best formula? Hum Reprod 2003; 18:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/34\">",
"      Gomez R, Gonzalez-Izquierdo M, Zimmermann RC, et al. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model. Endocrinology 2006; 147:5400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/35\">",
"      Alvarez C, Mart&iacute;-Bonmat&iacute; L, Novella-Maestre E, et al. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab 2007; 92:2931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/36\">",
"      Mansour R, Aboulghar M, Serour G, et al. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome. Hum Reprod 2005; 20:3167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/37\">",
"      Garc&iacute;a-Velasco JA, Isaza V, Quea G, Pellicer A. Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing? Fertil Steril 2006; 85:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/38\">",
"      D'Angelo A, Amso N. \"Coasting\" (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 2002; :CD002811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/39\">",
"      D'Angelo A, Amso NN. Embryo freezing for preventing ovarian hyperstimulation syndrome: a Cochrane review. Hum Reprod 2002; 17:2787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/40\">",
"      Ludwig M, Felberbaum RE, Devroey P, et al. Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction. Arch Gynecol Obstet 2000; 264:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/41\">",
"      Al-Inany H, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 2001; :CD001750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/42\">",
"      Bellver J, Mu&ntilde;oz EA, Ballesteros A, et al. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study. Hum Reprod 2003; 18:2283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/43\">",
"      Gokmen O, Ugur M, Ekin M, et al. Intravenous albumin versus hydroxyethyl starch for the prevention of ovarian hyperstimulation in an in-vitro fertilization programme: a prospective randomized placebo controlled study. Eur J Obstet Gynecol Reprod Biol 2001; 96:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/44\">",
"      Lainas T, Petsas G, Stavropoulou G, et al. Administration of methylprednisolone to prevent severe ovarian hyperstimulation syndrome in patients undergoing in vitro fertilization. Fertil Steril 2002; 78:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22647/abstract/45\">",
"      Tan SL, Balen A, el Hussein E, et al. The administration of glucocorticoids for the prevention of ovarian hyperstimulation syndrome in in vitro fertilization: a prospective randomized study. Fertil Steril 1992; 58:378.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7412 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-109.224.62.197-C12E3FDE9F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22647=[""].join("\n");
var outline_f22_7_22647=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ROLE OF TREATMENT REGIMENS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Gonadotropin dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Ovulatory trigger",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Exogenous hCG",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - GnRH agonist",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Recombinant hLH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MONITORING WITH SERUM ESTRADIOL AND TVUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      OTHER PREVENTIVE STRATEGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Coasting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Transforming to an IVF cycle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Intravenous albumin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Dopamine agonists",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/41/35479?source=related_link\">",
"      Classification and treatment of ovarian hyperstimulation syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39495?source=related_link\">",
"      Diagnosis of polycystic ovary syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/56/37770?source=related_link\">",
"      In vitro fertilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=related_link\">",
"      Overview of ovulation induction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/17/16660?source=related_link\">",
"      Pathogenesis of ovarian hyperstimulation syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_7_22648="Placental malaria infection";
var content_f22_7_22648=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51415&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51415&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Placental malaria infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hematoxylin and eosin stained placental parenchyma with malarial sequestration. The intervillous space demonstrates numerous infected red blood cells and hemozoin pigment in red blood cells and histiocytes. The infant was liveborn at 38 weeks of gestation. The blue arrows point to examples of red blood cells containing pigment and the black arrow points to an example of a pigment-containing histiocyte.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla J Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22648=[""].join("\n");
var outline_f22_7_22648=null;
var title_f22_7_22649="Eosinophilic folliculitis histology low power view";
var content_f22_7_22649=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F78005%7EPC%2F67192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F78005%7EPC%2F67192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Eosinophilic folliculitis histology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 292px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This low-power photomicrograph demonstrates spongiotic change with exocytosis extending from the sebaceous gland and its duct into the follicular epithelium of the infundibulum. For reasons which are not understood, the inflammatory process in HIV-associated eosinophilic folliculitis appears to be focused in these areas of the follicular apparatus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Whitney High, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Eosinophilic folliculitis histology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 271px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This high-power photomicrograph demonstrates the preponderance of eosinophils within the follicular inflammatory infiltrate in the infundibulum and sebaceous gland. Eventually, the number of eosinophils becomes so numerous that an infundibular eosinophilic pustule may develop.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Whitney High, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22649=[""].join("\n");
var outline_f22_7_22649=null;
var title_f22_7_22650="Pelvic trauma: Initial evaluation and management";
var content_f22_7_22650=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pelvic trauma: Initial evaluation and management",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/7/22650/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/7/22650/contributors\">",
"     James Fiechtl, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/7/22650/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/7/22650/contributors\">",
"     Maria E Moreira, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/7/22650/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/7/22650/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/7/22650/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/7/22650/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvis injuries range from the benign to life threatening. They include pelvic ring fractures, acetabular fractures, and avulsion injuries. The majority of pelvis injuries are due to high energy blunt trauma, although frail and elderly patients may sustain such injuries from a low energy mechanism (ie, fall). High energy trauma increases the likelihood of concomitant injuries, likely involving the abdominal and pelvic viscera.",
"   </p>",
"   <p>",
"    Bony pelvic injuries in adults will be reviewed here. Abdominal injuries and other aspects of trauma, including initial management, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=see_link\">",
"     \"Initial evaluation and management of blunt abdominal trauma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/11/35002?source=see_link\">",
"     \"Initial management of trauma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Incidence and mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic fractures represent approximately 3 percent of skeletal injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/1\">",
"     1",
"    </a>",
"    ]. Overall mortality from pelvic fractures ranges from 5 to 16 percent. The mortality rate associated with acetabular fractures is 3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/2\">",
"     2",
"    </a>",
"    ], while open pelvic fractures, which comprise 2 to 4 percent of all pelvic fractures, are associated with a mortality rate of up to 45 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/1,3-5\">",
"     1,3-5",
"    </a>",
"    ]. Most fatalities stem from associated internal injuries; deaths attributed solely to pelvic fractures range from 0.4 to 0.8 percent of trauma fatalities [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/4,6\">",
"     4,6",
"    </a>",
"    ]. Patients aged greater than 65 with pelvic fractures have a mortality rate of approximately 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/7\">",
"     7",
"    </a>",
"    ]. Overall, pelvic fractures are associated with an increased risk of death among trauma patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An Australian study of pelvic ring fractures demonstrated an incidence of 23 per 100,000 persons per year, while a British study found the incidence of acetabular fractures to be 3 per 100,000 persons per year [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Reviews of two large trauma registries found the incidence of pelvic ring fractures among admitted trauma patients to be 8 and 9.3 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/6,12\">",
"     6,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for pelvic fractures include low bone mass, smoking, hysterectomy, older age, and a propensity to fall [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/13\">",
"     13",
"    </a>",
"    ]. Age greater than 60 years in patients with significant pelvic fractures predicts a higher likelihood of bleeding requiring angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common mechanisms for pelvic fractures include motor vehicle collisions and motorcycle accidents (43 to 58 percent), pedestrians struck by a motor vehicle (20 to 22 percent), and falls (5 to 30 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/6,10,16\">",
"     6,10,16",
"    </a>",
"    ]. Similar mechanisms lead to acetabular fractures, but the percentage caused by motor vehicle collisions and motorcycle accidents is higher (80.5 to 83.6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/2,17\">",
"     2,17",
"    </a>",
"    ]. Avulsion fractures usually result from sudden, forceful contraction of a muscle in skeletally immature athletes aged 14 to 17 years [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study looking at 1851 motor vehicle accident patients, of whom 511 had pelvic fractures, found a higher incidence of pelvic fractures among those who sustained near side lateral impacts and reported that the use of seat belts was associated with fewer pelvic fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/19\">",
"     19",
"    </a>",
"    ]. Another study of 240 motor vehicle accident victims, 38 with pelvic ring fractures, also found an association with near side lateral impact crashes, but no decrease in pelvic ring injury with seat belt use [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/20\">",
"     20",
"    </a>",
"    ]. The effect of near side lateral impact on injury rates may change with the introduction of side torso airbags in automobiles, which occurred subsequent to the collection of much of the data used for these studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Associated injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvis injuries from high energy trauma frequently cause concomitant internal injuries, which may include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Hemorrhage",
"      </strong>",
"      &ndash; Life-threatening hemorrhage can occur. Venous bleeding is the source in 80 to 90 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/21\">",
"       21",
"      </a>",
"      ]. In one case series, 38.5 percent of hospitalized trauma patients with pelvic fractures required transfusion [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/12\">",
"       12",
"      </a>",
"      ]. In another series, 34 percent of trauma patients with isolated pelvis and acetabulum fractures required blood transfusions [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/22\">",
"       22",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Although complex pelvic injuries with major ligament disruption more often require transfusion, hemorrhage can accompany any pelvic fracture pattern [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]. Factors associated with hemorrhage requiring treatment with angiographic embolization include sacroiliac joint disruption, prolonged hypotension (defined as systolic blood pressure &lt;100 mmHg), and female gender [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Intraabdominal",
"      </strong>",
"      &ndash; Such injury occurs in 16.5 percent of patients with pelvic trauma [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/12\">",
"       12",
"      </a>",
"      ]. Both visceral organs (eg, liver, spleen) and bowel may be involved [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/5,12\">",
"       5,12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=see_link\">",
"       \"Initial evaluation and management of blunt abdominal trauma in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Bladder and urethra",
"      </strong>",
"      &ndash; The bladder is injured in approximately 3.4 percent and the urethra in 1 percent of pelvic trauma cases [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/25\">",
"       25",
"      </a>",
"      ]. Males are 10 times more likely to sustain urethral injuries (1.5 versus 0.15 percent). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18425?source=see_link\">",
"       \"Blunt genitourinary trauma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Neurologic",
"      </strong>",
"      &ndash; Nerve deficits associated with pelvic ring disruptions occur in 10 to 15 percent of pelvic trauma cases, with higher rates (up to 50 percent) in zone 3 sacral fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. The incidence increases with the degree of instability: 1.5 percent in stable fractures versus 14.4 percent in unstable fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/28\">",
"       28",
"      </a>",
"      ]. The most common sites include the L5 and S1 nerve roots and isolated peripheral nerves [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/28\">",
"       28",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Fracture types'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Thoracic aorta rupture",
"      </strong>",
"      &ndash; Dissection of the thoracic aorta occurs in 1.4 percent of blunt trauma patients with a pelvic fracture, compared with 0.3 percent of all blunt trauma patients [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Acetabular fractures, even in isolation, are associated with similar rates of concomitant injuries and require thorough evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bony pelvis consists of the sacrum, coccyx, and three innominate bones: the ilium, ischium, and pubis. The ilium, ischium, and pubis fuse to form the acetabulum. The acetabulum is classically described as having an anterior column (anterior iliac wing, superior pubic ramus, and anterior wall of the acetabulum) and a posterior column (ischium, ischial tuberosity, and posterior wall of the acetabulum) (",
"    <a class=\"graphic graphic_figure graphicRef76695 \" href=\"UTD.htm?26/17/26900\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The strength and stability of the pelvis relies on the strong ligaments connecting the sacrum with the other pelvic bones. These ligaments include the sacroiliac ligament complex (anterior and posterior portions), sacrospinous, and sacrotuberous. Additional pelvic strength comes from the symphyseal ligaments running from pubis to pubis, and ligaments between the lumbar spine and pelvic ring, such as the iliolumbar and lumbosacral. Disruption of these ligaments leads to pelvic instability (",
"    <a class=\"graphic graphic_figure graphicRef82199 \" href=\"UTD.htm?16/29/16850\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef57811 \" href=\"UTD.htm?5/56/6026\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Within the bony pelvis lie the pelvic viscera, an extensive vascular system, and a rich neural network. The pelvis contains the rectum, anal canal, and bladder. In females, the urethra, uterus, ovaries, and vagina also lie within the pelvis (",
"    <a class=\"graphic graphic_figure graphicRef66158 \" href=\"UTD.htm?21/35/22069\">",
"     figure 4",
"    </a>",
"    ). The prostate is found in males. All these structures require evaluation in pelvis injuries.",
"   </p>",
"   <p>",
"    The pelvic arterial system has anatomic variability especially the internal iliac artery and its branches (",
"    <a class=\"graphic graphic_figure graphicRef65019 \" href=\"UTD.htm?4/10/4265\">",
"     figure 5",
"    </a>",
"    ). Usually, the two common iliac arteries divide at the level of the pelvic brim. The external iliac artery follows the pelvic brim to exit the pelvis underneath the inguinal ligament. The internal iliac artery lies more posterior in the pelvis, particularly the posterior division as it overlies the sacroiliac joint. The posterior branch divides into the superior gluteal, iliolumbar, and lateral sacral arteries. The anterior division has many more branches; most important are the obturator and internal pudendal arteries, which can be injured in pubic rami fractures (",
"    <a class=\"graphic graphic_figure graphicRef73935 \" href=\"UTD.htm?12/19/12600\">",
"     figure 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The pelvic venous system consists of veins that parallel the arterial system and a venous plexus that lies anterior to the sacrum (",
"    <a class=\"graphic graphic_figure graphicRef59871 \" href=\"UTD.htm?35/35/36408\">",
"     figure 7",
"    </a>",
"    ). This plexus contains many thin-walled veins. This plexus is highly susceptible to damage with sacroiliac injuries and is a common source of bleeding.",
"   </p>",
"   <p>",
"    The neural network in the pelvis, the lumbosacral plexus, arises primarily from the nerve roots of L4 to S3 (",
"    <a class=\"graphic graphic_table graphicRef74353 \" href=\"UTD.htm?30/42/31404\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef56679 \" href=\"UTD.htm?10/7/10362\">",
"     figure 8",
"    </a>",
"    ). The sacral nerves exit through the sacral neural foramina and can be injured with sacral fractures (",
"    <a class=\"graphic graphic_figure graphicRef71171 \" href=\"UTD.htm?36/1/36887\">",
"     figure 9",
"    </a>",
"    ). Injuries to these nerves can result in bladder, bowel, and sexual dysfunction (",
"    <a class=\"graphic graphic_figure graphicRef73935 \" href=\"UTD.htm?12/19/12600\">",
"     figure 6",
"    </a>",
"    ). Although they do not arise from the lumbosacral plexus, the femoral and obturator nerves lie within the pelvis and may be injured with pelvic trauma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     FRACTURE TYPES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic fractures include ring disruptions, sacral fractures, acetabular fractures, and avulsion injuries. Significant hemorrhage may accompany any fracture pattern. However, patients with stable fractures (no operative intervention required) and no other significant injuries who are hemodynamically stable at presentation seldom have major bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Pelvic ring disruptions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bony pelvis forms a ring. When the ring is broken, most often two fractures occur. Therefore, clinicians should examine radiographs closely for additional injuries whenever a pelvis fracture is identified. &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    The elderly and athletes represent two exceptions to the general principle of grouped pelvic fractures. The elderly can sustain isolated rami or sacral fractures due to minor trauma and osteopenia. In addition, isolated fractures are occasionally seen in low energy falls and straddle type injuries. Avulsion fractures from sudden, forceful contraction of a muscle may occur in skeletally immature athletes.",
"   </p>",
"   <p>",
"    Several classification schemes for pelvic ring disruptions have been proposed. This review uses the Young and Burgess classification scheme because it incorporates the mechanism of injury and the direction of the involved forces (",
"    <a class=\"graphic graphic_figure graphicRef81214 \" href=\"UTD.htm?26/40/27268\">",
"     figure 10",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef55023 \" href=\"UTD.htm?37/61/38875\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While Young and Burgess found a correlation between major ligamentous injury (Lateral compression III, Anteroposterior compression II and III) and an increased risk of hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/30\">",
"     30",
"    </a>",
"    ], subsequent studies have failed to demonstrate a consistent correlation between injury type and mortality or the need for angiographic embolization [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. However, the largest review, involving 1248 pelvic fractures, reported that patients with unstable fracture patterns (Lateral compression",
"    <span class=\"nowrap\">",
"     II/III,",
"    </span>",
"    anteroposterior compression",
"    <span class=\"nowrap\">",
"     II/III,",
"    </span>",
"    vertical shear) required twice the transfusion rate of patients with stable injuries (4.9 versus 2.4 units) and sustained increased mortality (11.5 versus 7.9 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/33\">",
"     33",
"    </a>",
"    ]. One prospective observational study found that sacroiliac joint disruption, regardless of the Young-Burgess classification, predicts the need for angiographic embolization (OR 4.5; 95% CI 1.6-12.6) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/24\">",
"     24",
"    </a>",
"    ]. Overall, evidence suggests that patients who sustain a major injury to the posterior pelvic ring are more likely to have complications.",
"   </p>",
"   <p>",
"    The Young and Burgess classification is as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Lateral compression injuries",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Type 1 &ndash; Most common of this type. Sacral compression fracture on the side of impact with either unilateral or bilateral rami fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75305 \" href=\"UTD.htm?19/9/19605\">",
"       image 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Type 2 &ndash; Crescent (iliac wing) fracture on the side of impact (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef54293 \" href=\"UTD.htm?26/33/27154\">",
"       image 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Type 3 &ndash; Type 1 or 2 injury on the side of impact, but the force extends to the opposite hemipelvis, creating an open book injury on the side opposite the impact (also known as the \"wind-swept pelvis\") (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef68155 \" href=\"UTD.htm?42/62/44005\">",
"       image 3",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Anteroposterior compression injuries",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Type 1 &ndash; Involves slight widening of the pubic symphysis, usually less than 2 cm, with intact posterior pelvic ring ligaments (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef50783 \" href=\"UTD.htm?38/39/39537\">",
"       image 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Type 2 &ndash; Widening of the anterior sacroiliac joint occurs due to disruption of the anterior portion of the sacroiliac, sacrotuberous, and sacrospinous ligaments. The anterior pelvic ring can demonstrate either a widened pubic symphysis or rami fractures. The posterior portion of the sacroiliac ligament remains intact (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef62560 \" href=\"UTD.htm?22/62/23522\">",
"       image 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef72320 \" href=\"UTD.htm?20/52/21317\">",
"       image 6",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Type 3 &ndash; Complete disruption of the sacroiliac joint with anterior pelvic ring injuries similar to type 2 (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51376 \" href=\"UTD.htm?9/49/10005\">",
"       image 7",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Vertical shear injuries",
"      </strong>",
"      &ndash; The hemipelvis is displaced superiorly or posteriorly due to a longitudinal force applied to the pelvis. Anterior pelvic ring injuries can include either widening of the pubic symphysis or unilateral or bilateral rami fractures. Posterior pelvic ring injuries occur most commonly through the sacroiliac joint but can involve fractures of the iliac wing or sacrum (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef71651 \" href=\"UTD.htm?11/41/11921\">",
"       image 8",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef52384 \" href=\"UTD.htm?27/41/28309\">",
"       image 9",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Combined mechanisms",
"      </strong>",
"      &ndash; Combinations of the injury patterns described above can occur. Lateral compression and vertical shear is the most common.",
"     </li>",
"     <li>",
"      <strong>",
"       Open-book fracture",
"      </strong>",
"      &ndash; Open-book pelvic fracture is a common term used to describe pelvic ring disruptions (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73047 \" href=\"UTD.htm?13/32/13824\">",
"       image 10",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef53056 \" href=\"UTD.htm?43/5/44112\">",
"       image 11",
"      </a>",
"      ). This fracture encompasses an anterior injury (either widening of the pubic symphysis or rami fractures or both) and a posterior pelvic fracture or ligamentous injury. Lateral compression, anteroposterior compression, and vertical shear injuries may all be termed open-book based upon the extent of injury and anterior widening. When the anterior pelvic ring widens more than 2.5 cm, the posterior pelvis (especially the anterior portion of the sacroiliac ligamentous complex) is frequently injured, increasing the risk of hemorrhage.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Sacral fracture classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Denis and colleagues further classified sacral fractures to assist with predicting neurologic injury [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/27\">",
"     27",
"    </a>",
"    ]. Their classification scheme, along with the frequency of neurologic injury, is as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Zone 1 &ndash; Lateral to the sacral neural foramina (5.9 percent, usually L5 root)",
"     </li>",
"     <li>",
"      Zone 2 &ndash; Through the sacral neural foramina (28.4 percent, predominately sciatica with rare bladder or bowel involvement)",
"     </li>",
"     <li>",
"      Zone 3 &ndash; Medial to the sacral neural foramina through the central canal (&ge;50 percent; most involve bowel, bladder, or sexual dysfunction)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Acetabular fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classification scheme created by Letournel and Judet is used most often to describe acetabular fractures (",
"    <a class=\"graphic graphic_figure graphicRef57299 \" href=\"UTD.htm?16/37/16985\">",
"     figure 11",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/34\">",
"     34",
"    </a>",
"    ]. The plain radiograph views used to assess acetabular fractures are described in the attached figure (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69019 \" href=\"UTD.htm?10/10/10405\">",
"     image 12",
"    </a>",
"    ). This scheme includes the following injury types:",
"   </p>",
"   <p>",
"    Simple fractures &ndash; Five types (",
"    <a class=\"graphic graphic_figure graphicRef82681 \" href=\"UTD.htm?43/41/44694\">",
"     figure 12",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Posterior wall &ndash; Most common pattern (23.3 percent); fracture of the posterior articular surface with intact posterior column (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef66251 \" href=\"UTD.htm?12/22/12643\">",
"       image 13",
"      </a>",
"      ); look for associated posterior femoral head dislocation (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef50887 \" href=\"UTD.htm?31/56/32642\">",
"       image 14",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/11\">",
"       11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Posterior column &ndash; Ilioischial disruption; fracture can be anywhere from the ischial spine to the sciatic notch; femoral dislocation when present tends to be medial (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef66251 \" href=\"UTD.htm?12/22/12643\">",
"       image 13",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Anterior wall &ndash; Fracture to a small area of the upper anterior acetabulum (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78257 \" href=\"UTD.htm?26/50/27427\">",
"       image 15",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Anterior column &ndash; Disruption of the iliopectineal line; associated anterior femoral head dislocation common (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef50542 \" href=\"UTD.htm?32/17/33044\">",
"       image 16",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Transverse &ndash; Fracture line crosses through both columns causing a separation of the acetabular articular surface (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75638 \" href=\"UTD.htm?40/24/41345\">",
"       image 17",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Complex fractures - Combinations of simple fracture patterns (",
"      <a class=\"graphic graphic_figure graphicRef55805 \" href=\"UTD.htm?13/61/14295\">",
"       figure 13",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      T-shaped &ndash; Combination of transverse fracture and a vertical fracture resulting in two ischiopubic fragments (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef54187 \" href=\"UTD.htm?29/31/30194\">",
"       image 18",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Posterior wall and posterior column &ndash; Posterior column and posterior wall significantly displaced from one another; risk of sciatic nerve injury from posterior hip dislocation that often accompanies such injuries (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef62873 \" href=\"UTD.htm?40/9/41109\">",
"       image 19",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Transverse and posterior wall &ndash; Combination of transverse and posterior wall fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78042 \" href=\"UTD.htm?40/4/41028\">",
"       image 20",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Anterior column and posterior hemi-transverse &ndash; Anterior wall or column fracture with a posterior column fracture in a transverse pattern (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef62299 \" href=\"UTD.htm?12/3/12340\">",
"       image 21",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Both columns &ndash; Most complex acetabular fracture; &ldquo;floating&rdquo; acetabulum with anterior and posterior columns separated from one another and the central skeleton; the entire acetabulum is separated and can remain congruent with the femoral head (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67549 \" href=\"UTD.htm?33/16/34049\">",
"       image 22",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Avulsion fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Avulsion fractures most often occur in skeletally immature athletes aged 14 to 17 years, but may occur in high energy trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/18\">",
"     18",
"    </a>",
"    ]. Sudden forceful muscular contraction is the usual cause. The most common sites and muscles involved are the anterior superior iliac spine (sartorius), anterior inferior iliac spine (rectus femoris), ischial tuberosity (hamstrings), and less commonly the lesser trochanter (iliopsoas) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54327 \" href=\"UTD.htm?41/56/42880\">",
"     image 23",
"    </a>",
"    ). In adults, avulsion fractures in the absence of trauma should be considered pathological until proven otherwise.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PREHOSPITAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with all trauma patients, highest priority is given to stabilizing the airway, breathing, and circulation, and to minimizing on-scene time. Prehospital trauma management is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/4/17482?source=see_link\">",
"     \"Prehospital care of the adult trauma patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In pelvic trauma, the primary goal of EMS personnel is recognizing possible injuries based upon mechanism and physical assessment. Unstable pelvic injuries, such as \"open-book\" fractures involving disruption of the sacroiliac joints, are associated with retroperitoneal hemorrhage, which can be severe. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Fracture types'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    When a pelvis injury is suspected in a hemodynamically unstable patient, if possible, paramedics should stabilize or \"close\" the pelvis by securing either a sheet or a commercial binder around it. This reduces pelvic volume and stabilizes fracture fragments, thereby reducing the risk of major hemorrhage. Paramedics can also tie the legs together to stabilize the lower extremities in internal rotation, which reduces pelvic volume. Care should be taken to not tie or bind the pelvis too tightly. The goal pelvic binding is stabilization and existing injuries may be exacerbated by over-reduction. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Pelvis injury'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients sustain pelvis injuries from high energy trauma and have multiple injuries to be addressed. Often the condition of the trauma patient limits the clinician's ability to obtain a complete history. Prehospital providers can describe the likely mechanism of injury, accident scene (eg, intrusion into the passenger compartment of an automobile), and their initial assessment. In addition to the standard trauma history (eg, AMPLE: Allergies, Medications [especially anti-coagulants], Past history, Last meal, Events), the following facts are useful in the setting of possible pelvic trauma:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mechanism of injury",
"     </li>",
"     <li>",
"      Ambulatory at the accident scene",
"     </li>",
"     <li>",
"      Location of pain",
"     </li>",
"     <li>",
"      Bowel or bladder incontinence",
"     </li>",
"     <li>",
"      Numbness or weakness",
"     </li>",
"     <li>",
"      Bleeding: hematuria, rectal or vaginal bleeding",
"     </li>",
"     <li>",
"      Last menstrual period",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial inspection should include a search for external bleeding, ecchymosis (flank, perineal, and scrotal), blood at the penile meatus, vaginal bleeding, and the position of the lower extremities and iliac crests. Do not neglect to inspect the back, gluteal region, and pannicular folds.",
"   </p>",
"   <p>",
"    Palpation of bony landmarks, range of motion (if there is no obvious deformity or significant pain), and a thorough neurovascular examination should be performed. The important bony landmarks to palpate include the iliac crests, pubic symphysis, sacrum, sacroiliac joints, and greater trochanters.",
"   </p>",
"   <p>",
"    Rectal and vaginal examinations should be carefully completed to assess for open fractures. These examinations should include evaluation for palpable bony fragments, integrity of the rectal and vaginal walls, gross blood, and a high riding prostate. Assessing for open pelvic fractures represents one instance when a digital rectal examination provides useful information beyond clinical judgment in trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/35\">",
"     35",
"    </a>",
"    ]. Care should be taken to avoid injury to the examiner from bony fragments.",
"   </p>",
"   <p>",
"    Compression of the pelvis should be done in a gentle manner, in order not to displace fracture fragments or exacerbate injuries. Once a pelvic injury is detected, repeated compression should be avoided. According to retrospective data, instability with compression of the pelvis has limited sensitivity for detecting a pelvic fracture (8 percent), including unstable pelvic fractures (26 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/36\">",
"     36",
"    </a>",
"    ]. However, when present, such instability is highly specific for both stable and unstable fractures (approximately 99 percent for each).",
"   </p>",
"   <p>",
"    In awake trauma patients (Glasgow Coma Scale 14 or 15), the physical examination is highly sensitive for significant pelvic fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/36-39\">",
"     36-39",
"    </a>",
"    ]. In a prospective study comparing a focused examination protocol to CT scan, pain with palpation of the sacrum and sacroiliac joint had the greatest sensitivity (98 percent) for detecting posterior pelvic ring injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/39\">",
"     39",
"    </a>",
"    ]. A study based upon prospectively collected data found that among patients with signs of blunt pelvic trauma, those who sustained pelvic fractures had more severe injuries overall and were more likely to be hypotensive [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinician should",
"    <strong>",
"     not",
"    </strong>",
"    rely upon the physical examination in severely injured or intubated trauma patients. In one prospective series, physical examination missed 20 percent of surgically significant pelvic fractures in such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     INITIAL MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Initial assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;In all trauma patients, stabilization of the airway, breathing, and circulation takes precedence. The initial management of trauma patients is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/11/35002?source=see_link\">",
"     \"Initial management of trauma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Features of the history and physical examination, identified during the primary and secondary surveys, will direct attention to possible pelvis injuries. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Clinical features'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Special care should be taken with pregnant patients with pelvis injuries as their fetal mortality rate is 35 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22569?source=see_link\">",
"     \"Trauma in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Diagnostic tests",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;A bedside ultrasound examination (ie, the Focused Assessment with Sonography in Trauma, or FAST) is performed in the great majority of blunt trauma patients. Its role in the assessment of pelvic trauma has yet to be clearly defined. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/30/7658?source=see_link\">",
"     \"Emergency ultrasound in adults with abdominal and thoracic trauma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Evaluation of the hemoperitoneum in the setting of a pelvic fracture can be difficult, especially in the hemodynamically unstable patient. Two retrospective studies of the FAST examination in blunt trauma patients with pelvic fractures found the test's sensitivity to be 26 and 81 percent, respectively, with specificities of 96 and 87 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Although the accuracy of the FAST examination is limited in patients with pelvic fractures, its high specificity and bedside availability has led to its incorporation into pelvic management protocols [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/16,42-44\">",
"     16,42-44",
"    </a>",
"    ]. However, further evaluation is needed whenever the examination is negative and either the patient is unstable or clinical suspicion for injury remains. &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Diagnostic peritoneal aspirate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic peritoneal aspirate (DPA) is used in patients with negative FAST studies and persistent hemodynamic instability to determine rapidly whether the source of bleeding is peritoneal or retroperitoneal. An aspirate of 10 mL or more of gross blood is considered positive for intraperitoneal bleeding. The role of DPA in the assessment of pelvic trauma is discussed below; the general role of DPA and diagnostic peritoneal lavage (DPL) in abdominal trauma is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=see_link&amp;anchor=H13#H13\">",
"     \"Initial evaluation and management of blunt abdominal trauma in adults\", section on 'Diagnostic peritoneal lavage'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the role of DPA in pelvic trauma remains unclear, it may be an important tool for determining whether intraabdominal free fluid detected by ultrasound is blood or urine. This distinction can be of great importance in unstable patients with multiple trauma that includes pelvic injuries. In a single-center, retrospective study of 87 patients with major pelvis trauma, free peritoneal fluid detected by ultrasound was found to be urine rather than blood in 19 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Plain radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;A plain x-ray of the pelvis is obtained in hemodynamically unstable patients; its utility in stable patients and those undergoing computed tomography is debatable [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. We do",
"    <strong>",
"     not",
"    </strong>",
"    routinely obtain a plain x-ray in patients who meet",
"    <strong>",
"     all",
"    </strong>",
"    the following criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Glasgow coma scale &gt;13",
"     </li>",
"     <li>",
"      No pelvic, abdominal, or back complaints",
"     </li>",
"     <li>",
"      No tenderness in the lower abdomen, lower back, groin, or bony pelvis (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Physical examination'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Traditional teaching in Advanced Trauma Life Support&reg; (ATLS&reg;) is to obtain a portable AP pelvis radiograph in all trauma patients suspected to have a pelvis injury on the basis of mechanism or physical findings. However, many clinicians question the utility of a plain x-ray in screening for pelvis fractures in hemodynamically stable blunt trauma patients. Several observational studies have found plain x-ray to have limited sensitivity and no effect upon management in such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/45,47,48\">",
"     45,47,48",
"    </a>",
"    ]. One important caveat to these studies is that all patients underwent multidetector computed tomography (MDCT) scans, which guided treatment. In hospitals without MDCT scanning and in hemodynamically unstable patients, portable pelvis radiographs should be performed.",
"   </p>",
"   <p>",
"    The plain AP x-ray is used to assess for significant pelvic fractures, specifically displaced fractures, open-book injuries, and posterior pelvis injuries. Example radiographs for many pelvic injuries are provided above. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Fracture types'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Remember that when the pelvic ring is broken most often two fractures occur, although this may not be the case in elder patients. Also keep in mind that passive recoil of the pelvis due to intact muscular attachments (ie, pelvic recoil) can make it difficult to appreciate the extent of pelvic fracture displacement and contribute to the limited sensitivity of plain pelvis radiographs. In a study of 15 cadavers with simulated pelvic trauma, pelvic recoil was reported to occur in approximately 40 percent of open-book injuries and 80 percent of lateral compression injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The posterior stability of the pelvic ring is enhanced by the iliolumbar ligaments that connect the L5 transverse process to the iliac crest. Any fracture of this transverse process weakens the attachment. According to a retrospective case series, unstable pelvic fractures are approximately 9 times more likely when an L5 transverse process fracture occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once the patient has been stabilized and other injuries have been appropriately managed, specialized radiographs may be performed. These include",
"    <span class=\"nowrap\">",
"     inlet/outlet",
"    </span>",
"    and Judet views. The inlet view (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75305 \" href=\"UTD.htm?19/9/19605\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef65489 \" href=\"UTD.htm?34/26/35232\">",
"     figure 14",
"    </a>",
"    ) is obtained by projecting an x-ray beam tilted 40 degrees cephalad to better define the pelvic brim, while the outlet view (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75305 \" href=\"UTD.htm?19/9/19605\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef68451 \" href=\"UTD.htm?39/25/40336\">",
"     figure 15",
"    </a>",
"    ) uses an x-ray beam tilted 40 degrees caudal to better evaluate the sacrum and SI joints.",
"   </p>",
"   <p>",
"    To obtain Judet views, the patient is rolled 45 degrees to each side, creating iliac oblique and obturator oblique views. The iliac oblique highlights the posterior column and the anterior wall of the acetabulum while the obturator oblique illustrates the anterior column and the posterior wall (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50887 \" href=\"UTD.htm?31/56/32642\">",
"     image 14",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69019 \" href=\"UTD.htm?10/10/10405\">",
"     image 12",
"    </a>",
"    ). These views may be helpful to the orthopedic surgeon for operative planning and postoperative monitoring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     CT Scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gold standard for diagnosing pelvic injuries is multidetector computed tomography (MDCT) due to its high sensitivity and detailed delineation of fractures. MDCT can determine concomitant injuries, areas of arterial bleeding, and the extent of retroperitoneal hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. Most hemodynamically stable blunt trauma patients with a pelvic fracture should be evaluated with MDCT. Notable exceptions include elderly patients with isolated pubic rami fractures and athletes with avulsion fractures. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Avulsion fractures'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Clinicians should have a low threshold for obtaining a CT when an acetabular injury is suspected. These fractures can be subtle and difficult to appreciate on plain x-rays, particularly some involving the posterior acetabulum. Example CT images for a wide range of pelvic fractures are provided above. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Fracture types'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Retrograde cystourethrogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the physical examination reveals blood at the urethral meatus, a high riding prostate, or gross hematuria, ATLS guidelines recommend that a retrograde urethrogram be performed prior to Foley catheter placement. Genitourinary injuries are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18425?source=see_link\">",
"     \"Blunt genitourinary trauma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Initial stabilization and approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both pelvic and acetabular fractures have a high incidence of associated internal injuries. Once resuscitated and stabilized, patients with major pelvic injuries initially managed at nontrauma centers should be transferred to tertiary hospitals with trauma, orthopedic surgery, and ideally interventional radiology services. An algorithm for the management of blunt trauma patients with a significant pelvic fracture is provided (",
"    <a class=\"graphic graphic_algorithm graphicRef80701 \" href=\"UTD.htm?36/40/37518\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/42,44,53\">",
"     42,44,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The results of the trauma ultrasound examination (ie, FAST) determine initial treatment. Hemodynamically unstable patients with a positive FAST examination are treated with emergent celiotomy, pelvic stabilization, and preperitoneal packing; hemodynamically unstable patients with a negative FAST examination are evaluated with a diagnostic peritoneal aspirate (DPA). If the DPA is positive, the patients go for emergent celiotomy, pelvic stabilization, and preperitoneal packing, while those with a negative DPA are treated with pelvic stabilization and preperitoneal packing, and if necessary pelvic angiography. All hemodynamically stable patients with major pelvic fractures are evaluated with multidetector computed tomography (MDCT). The surgical management of severe pelvic trauma is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/16/25865?source=see_link\">",
"     \"Severe pelvic fracture in the adult trauma patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with uncontrollable hemorrhage from severe pelvic trauma, some centers have used intra-aortic balloon occlusion as a temporizing measure to control bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/54\">",
"     54",
"    </a>",
"    ]. Once stabilized, patients can be transferred for definitive treatment with angiography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Pelvis injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a significant pelvis injury is found or a patient with a pelvic fracture remains hemodynamically unstable, the pelvis should be \"wrapped\" with either a sheet or a commercial pelvic binder. \"Wrapping\" the pelvis reduces pelvic volume (creating a tamponade effect), stabilizes fracture fragments (reducing hemorrhage from the fracture sites), and improves patient comfort. Even fractures without an \"open-book\" component can be wrapped, the primary goal being fracture stabilization and not reduction.",
"   </p>",
"   <p>",
"    The simplest method for reducing pelvic volume is to tape the legs together in internal rotation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/55\">",
"     55",
"    </a>",
"    ]. Alternatively, a sheet wrapped circumferentially around the greater trochanters and held in place with towel clamps is effective at reducing pelvic volume while permitting trauma assessment (",
"    <a class=\"graphic graphic_picture graphicRef62544 \" href=\"UTD.htm?19/31/19958\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/56\">",
"     56",
"    </a>",
"    ].Commercial pelvic binders may also be used. Commercial devices include the Dallas Pelvic Binder, Geneva Belt, Stuart Splint, London Pelvic Splint, and the Trauma Pelvic Orthotic Device (TPOD&trade;) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/57\">",
"     57",
"    </a>",
"    ]. These splints are placed around the iliac crests (Dallas and Geneva) or the greater trochanters (London, TPOD, and simple sheets). To date, no controlled study has shown commercial devices to be clinically superior to sheets or taping.",
"   </p>",
"   <p>",
"    Great care should be taken not to over-reduce the fracture, especially with lateral compression injuries. Excessive reduction can create or increase an internal rotation deformity. Such a deformity places greater strain on the posterior pelvis, leading to greater diastasis, increased hemorrhage, and further injury. Over-reduction can be assessed clinically by the position of the patient's legs, greater trochanters, and patellae, which should lie in an anatomically neutral position.",
"   </p>",
"   <p>",
"    Radiographs should be obtained after splint application to assess the adequacy of reduction. In severe lateral compression injuries, the sheet or splint is placed only to stabilize the pelvis, not to compress it. Three devices, the SAM&reg; Pelvic Sling&trade; (",
"    <a class=\"graphic graphic_picture graphicRef61466 \" href=\"UTD.htm?43/34/44580\">",
"     picture 2",
"    </a>",
"    ), TPOD&trade;, and the Pelvic Circumferential Compression Device (PCCD), limit the amount of force that can be applied, reducing the chance of internal rotation even in lateral compression injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/57,58\">",
"     57,58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although sheets or commercial pelvic binders can be placed quickly and are effective, external fixators can also be placed in the emergency department by orthopedic or trauma surgeons to reduce fractures and control bleeding. In experienced hands, standard pelvic external fixators require approximately 15 minutes to place, but can interfere with abdominal surgery. Pelvic clamps (referred to as C-clamps) can be placed more quickly and may be rotated to avoid interfering with pelvic angiography or abdominal surgery.",
"   </p>",
"   <p>",
"    In addition to aggressive resuscitation, patients with open pelvic fractures (ie, with exposed bone) require treatment with broad spectrum IV antibiotics and prophylaxis against tetanus.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/61/26583?source=see_link\">",
"     Cefuroxime",
"    </a>",
"    is an appropriate choice.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     Vancomycin",
"    </a>",
"    should be added if concern exists for infection with methicillin-resistant Staphylococcus aureus. Prophylactic treatment should be administered within 6 hours of open trauma and continued for 72 hours. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/25/10646?source=see_link\">",
"     \"Treatment and prevention of osteomyelitis following trauma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Open fractures of the pelvis are not to be confused with pelvic open-BOOK fractures, which refer to injuries in which the pelvis has widened, and which may or may not be open fractures. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Fracture types'",
"    </a>",
"    above.) Open pelvis fractures generally require multidisciplinary management and extensive debridement in the operating room.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Acetabular injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with acetabular fractures have a high incidence of associated injuries and a full trauma assessment should be performed. Management of the fracture can include relocation of the femoral head if there is an associated hip dislocation or the placement of a traction pin (performed in conjunction with an orthopedic surgeon).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Avulsion injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Avulsion injuries are treated conservatively with rest, ice, protected weight bearing, and analgesics. Disagreement exists about operative repair; generally fragments displaced more than 2 cm are treated surgically [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13255578\">",
"    <span class=\"h3\">",
"     Minor pelvic fractures in elders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elder patients are at greater risk for occult pelvic fractures, primarily pubic rami and sacral insufficiency fractures. Advanced diagnostic imaging should be obtained for elder patients in whom a fracture is suspected on clinical grounds despite negative plain x-rays. These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/2/33831?source=see_link\">",
"     \"Minor pelvic fractures in the elderly\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Pitfalls and pearls",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treat patients with pelvis fractures as trauma patients. Pelvis injuries are associated with significant bleeding, concomitant internal injuries, and high mortality.",
"     </li>",
"     <li>",
"      Do not assume that the extent of bleeding correlates with the severity of the fracture pattern [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/31\">",
"       31",
"      </a>",
"      ]. Any pelvic fracture can cause significant bleeding. Elder patients may have life-threatening hemorrhage from pelvic fractures sustained in low energy falls.",
"     </li>",
"     <li>",
"      Do not underestimate the extent of the fracture based on plain radiographs. Posterior pelvis injuries (ligaments and sacral fractures) are difficult to assess on plain films; CT scanning is necessary.",
"     </li>",
"     <li>",
"      Obtain subspecialty consultation early for concerning signs or injuries. The management of pelvic injuries can be complex and often requires surgical stabilization or angiography.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     DEFINITIVE MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Specialty consultation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trauma and orthopedic surgeons should be involved early in the care of patients with significant pelvis injuries. Determining the definitive treatment can be complex and options include preperitoneal pelvic packing, operative stabilization of the pelvic fracture (internally or externally), and angiography for embolization of bleeding pelvic vessels. Emergency clinicians can assist their colleagues by starting the resuscitation, evaluating for hemoperitoneum, gathering resources, and notifying the operating room and angiography suite early, including the interventional radiologist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/16/25865?source=see_link\">",
"     \"Severe pelvic fracture in the adult trauma patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Orthopedic surgery consultation should be obtained for isolated pelvis injuries, following a negative trauma workup. Patients with minor injuries, such as avulsion fractures or isolated fractures of pubic rami, can be discharged home, provided the patient can move adequately and follow-up is ensured.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Transfer",
"    </span>",
"    &nbsp;&mdash;&nbsp;All trauma patients with significant pelvis injuries should be stabilized and transferred to a regional trauma center, ideally with interventional radiology capability. Complex isolated pelvis injuries should be transferred for definitive orthopedic care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mortality rates in patients with high-energy pelvic trauma are 10 to 16 percent and depend upon the severity of associated injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/4\">",
"     4",
"    </a>",
"    ]. Morbidity is also related to associated neurologic and genitourinary injuries. Overall, fewer than 50 percent of patients with pelvis injuries requiring operative repair return to their preinjury level of function [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/59\">",
"     59",
"    </a>",
"    ]. Osteoarthritis develops in 26.6 percent of acetabular fractures, while 75.1 percent have a good functional outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7468319\">",
"    <span class=\"h1\">",
"     PEDIATRIC CONSIDERATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6979610\">",
"    <span class=\"h2\">",
"     Anatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric bones are covered by a thicker periosteum and are more pliable than adult bones. In addition, the ligaments of children are relatively stronger than the adjacent bone, as are the tendons compared to their related apophyses. Due to these differences, avulsion fractures of the pelvis and isolated pelvic ring fractures are more common in children, although the most likely location for such injuries does not differ from adults. Significant force is required for a child to sustain a complete pelvic ring disruption involving the posterior elements. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Avulsion fractures'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H8\">",
"     'Pelvic ring disruptions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The presence of the triradiate cartilage, a secondary ossification center in the acetabular floor, can make the interpretation of plain radiographs of the pelvis difficult. The triradiate cartilage fuses between the ages of 14 to 16. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7468335\">",
"    <span class=\"h2\">",
"     Epidemiology and mechanism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Little has been published concerning pediatric pelvic trauma. Pelvic fractures occur less frequently in children than adults, with pelvic ring disruptions and avulsion injuries most commonly described. The reported incidence of pelvic fractures among children admitted to the hospital following blunt trauma ranges from 2.4 to 7.5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/60\">",
"     60",
"    </a>",
"    ]. According to one review that included 124 children with pelvic fractures, patients with such injuries represent 1.6 percent of all pediatric trauma admissions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/60\">",
"     60",
"    </a>",
"    ]. However, the true incidence of pediatric pelvic fractures is most likely higher, as suggested by a postmortem study of 66 blunt pediatric trauma deaths that found 93 percent had sustained posterior pelvic ring injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/61\">",
"     61",
"    </a>",
"    ]. In the review cited above, mortality among children with non-avulsion pelvic fractures was five percent. Unlike adults, children die less often from pelvic hemorrhage but more often from concomitant injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With the exception of avulsion injuries, pediatric pelvic fractures generally result from high-energy mechanisms, most often involving a child being struck by a motor vehicle (57.8 percent), followed by motor vehicle crashes (17.8 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/63\">",
"     63",
"    </a>",
"    ]. Avulsion fractures of the pelvis are more common in children, and can occur from less severe mechanisms. Published studies likely under-represent avulsion fractures as children with these injuries typically do not require hospital admission.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7468357\">",
"    <span class=\"h2\">",
"     Associated injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the exception of avulsion fractures, pediatric pelvic fractures result from high-energy mechanisms that often cause significant concomitant injury. The rate of associated injury increases with the severity of the pelvic fracture, but data is limited, and thus, it is difficult to characterize precisely which injuries occur and how frequently. Concomitant injuries may include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemorrhage &ndash; Life-threatening hemorrhage caused directly by pelvic fractures is uncommon in children, occurring in less than two percent of cases according to one review [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/63\">",
"       63",
"      </a>",
"      ]. However, bleeding from associated injuries does occur, as shown in one series in which 30 percent of patients required a blood transfusion [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/60\">",
"       60",
"      </a>",
"      ]. The sites of bleeding are primarily intraabdominal (eg, liver, spleen) and thoracic [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/63\">",
"       63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Head Injuries &ndash; Head injuries, ranging from facial lacerations to intracranial hemorrhage, occur in as many as 40 percent of children with pelvic fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/60\">",
"       60",
"      </a>",
"      ]. In one series of 39 children with pelvic ring fractures, approximately 8 percent of associated head trauma involved parenchymal brain injury and 10 percent were skull fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/64\">",
"       64",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Chest/Abdomen",
"      </span>",
"      &ndash; Approximately 15 to 33 percent of children with pelvic fractures sustain some type of thoracic or abdominal injury [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/60,63\">",
"       60,63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Genitourinary &ndash; According to a systematic review of studies involving over 1000 total pediatric pelvic injuries, the overall incidence of genitourinary injury associated with pelvic trauma is 11 to 12 percent, including urethra (26.4 percent), vagina (14.9 percent), bladder (10.7 percent), and rectum (10.7 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/63\">",
"       63",
"      </a>",
"      ]. As pelvic ring injuries become more extensive, the incidence of genitourinary injury increases to approximately 40 to 50 percent.",
"     </li>",
"     <li>",
"      Neurologic &ndash; The incidence of neurologic injury to the lumbosacral plexus is lower than adults, ranging from approximately 0.8 to 6.1 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/63\">",
"       63",
"      </a>",
"      ]. The incidence of concomitant spinal cord injury is approximately 3.2 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/63\">",
"       63",
"      </a>",
"      ]. Overall, the range of concomitant neurologic injuries sustained by children with severe pelvic trauma is similar to adults.",
"     </li>",
"     <li>",
"      Extremity &ndash; Fractures of the femur and tibia are the extremity injuries most often associated with pelvic trauma, occurring approximately 18 and 10.7 percent respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/63\">",
"       63",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7468372\">",
"    <span class=\"h2\">",
"     Imaging studies and fracture types",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain radiographs have limited sensitivity for detecting a pediatric pelvic ring fractures, ranging from 49 to 54 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/47,65\">",
"     47,65",
"    </a>",
"    ]. Two groups have proposed decision rules for obtaining radiographs in pediatric trauma patients but these have yet to be validated [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/66,67\">",
"     66,67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CT scan remains the gold standard for pelvic fracture diagnosis and assessment, but its advantages should be weighed against the long-term risks of excessive radiation exposure in children. No definitive guidelines exist for CT scan indications; however, we recommend CT scan imaging for patients with pelvic ring injuries found on plain radiographs to better assess posterior involvement and for patients requiring further evaluation for abdominal trauma (eg, signs associated with intra-abdominal injury present on examination or ultrasound). In addition, CT imaging is warranted in patients with findings consistent with an unstable pelvis. Isolated avulsion fractures identified by plain x-ray generally do not warrant additional imaging with CT. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=see_link\">",
"     \"Radiation-related risks of imaging studies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=see_link\">",
"     \"Overview of blunt abdominal trauma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several classification schemes have been used for pediatric pelvic fractures, including Tile, Young-Burgess, and Torode and Zeig. The modified Torode and Zeig classification includes four types of pelvic injuries:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type I &ndash; Avulsion injury",
"     </li>",
"     <li>",
"      Type II &ndash; Iliac wing fracture",
"     </li>",
"     <li>",
"      Type III &ndash; Simple ring fracture (stable)",
"     </li>",
"     <li>",
"      Type IV &ndash; Unstable ring disruption.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This system uses CT for better assessment of the posterior pelvic structures. Based upon the CT results, pelvic ring fractures are described as either IIIA (isolated anterior ring fractures) or IIIB (involving anterior and posterior ring, stable). Stable fractures are defined by pelvic stability with manual compression and less than 2 mm of displacement on CT. According to a retrospective study of 124 children with pelvic fractures, patients with Type IIIB injuries were three times more likely to require ICU admission and 3.5 times more likely to require a blood transfusion than patients with Type IIIA injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7468393\">",
"    <span class=\"h2\">",
"     Evaluation and management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation and management of pediatric pelvic trauma is similar to that performed in adults. Assessment and stabilization of the airway and breathing, circulation, and concomitant life-threatening injuries takes precedence. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Initial management'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=see_link\">",
"     \"Trauma management: Approach to the unstable child\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3477?source=see_link\">",
"     \"Trauma management: Unique pediatric considerations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Debate continues about the definitive surgical management of pediatric pelvic fractures. In all cases, orthopedic consultation should be obtained and transfer made to a tertiary care center as needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7468407\">",
"    <span class=\"h2\">",
"     Outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Outcome data regarding pediatric pelvic fracture is limited due to a lack of uniform treatment protocols and long-term follow-up. According to one review, over 30 percent of children will have some residual pain, limp, or scoliosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/7/22650/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/21/5459?source=see_link\">",
"       \"Patient information: Pelvic fracture (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most pelvis injuries require a significant amount of force. The most common mechanisms of injury include motor vehicle collisions and pedestrians struck by a motor vehicle. Associated injuries are frequent with the most common and worrisome being hemorrhage. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Anatomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pelvic fractures include ring disruptions, sacral fractures, acetabular fractures, and avulsion injuries. Significant hemorrhage may accompany any fracture pattern. Classification schemes are described in the text. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Fracture types'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Physical examination findings associated with an increased risk of pelvic injury include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Abnormal position of lower extremities",
"     </li>",
"     <li>",
"      Flank, perineal, or scrotal ecchymosis",
"     </li>",
"     <li>",
"      Tenderness over the bony pelvis, especially the sacrum and sacroiliac joints",
"     </li>",
"     <li>",
"      Focal lower extremity weakness or diminished sensation",
"     </li>",
"     <li>",
"      Hematuria or bleeding from the rectum or vagina",
"      <br/>",
"      <br/>",
"      Physical examination cannot be relied upon to detect significant pelvis injuries in the patient who is severely injured, intubated, or manifests an altered mental status. Examination of the pelvis to assess stability should be performed gently to avoid displacement of fractures and increased bleeding. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A bedside ultrasound examination (ie, Focused Assessment with Sonography in Trauma, or FAST) is performed in the great majority of blunt trauma patients. Its role in the assessment of pelvic trauma has yet to be clearly defined. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Ultrasound'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A plain x-ray of the pelvis is obtained in hemodynamically unstable patients; its utility in stable patients and those undergoing computed tomography (CT) is debatable. We do NOT routinely obtain a plain x-ray in patients who meet the following criteria:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Glasgow coma scale &gt;13",
"     </li>",
"     <li>",
"      No pelvic, abdominal, or back complaints",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      No tenderness in the lower abdomen, lower back, groin, or bony pelvis. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Plain radiograph'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multidetector CT scan remains the preferred method for the evaluation of all hemodynamically stable patients with pelvic trauma. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'CT Scan'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Significant pelvis injuries should be immobilized using either a sheet or a commercial pelvic binder wrapped circumferentially around the greater trochanters. The goal is to stabilize injuries; over-reduction of fractures by wrapping too tightly must be avoided. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Pelvis injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An algorithm for the management of blunt trauma patients with a significant pelvic fracture is provided (",
"      <a class=\"graphic graphic_algorithm graphicRef80701 \" href=\"UTD.htm?36/40/37518\">",
"       algorithm 1",
"      </a>",
"      ). Hemodynamically unstable patients with a positive FAST exam are treated with emergent celiotomy, pelvic stabilization,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      preperitoneal packing; hemodynamically unstable patients with a negative FAST exam are evaluated with a diagnostic peritoneal aspirate (DPA). If the DPA is positive, the patients go for emergent celiotomy, while those with a negative DPA go for pelvic stabilization, preperitoneal packing, or pelvic angiography if needed.",
"     </li>",
"     <li>",
"      Major pelvic injuries require early consultation with trauma and orthopedic surgery or expeditious transfer to a regional trauma center. Early notification of the operating room and angiography suite staff, including the interventional radiologist, can save valuable time in the hemodynamically unstable patients with a pelvic fracture. (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Definitive management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3484032\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the untimely death of John Marx, MD, who passed away in July 2012. We wish to acknowledge Dr. Marx's dedication and his many contributions to UpToDate, in particular, his work as editor-in-chief for Emergency Medicine and as a section editor and author for Adult Trauma.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/1\">",
"      Grotz MR, Allami MK, Harwood P, et al. Open pelvic fractures: epidemiology, current concepts of management and outcome. Injury 2005; 36:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/2\">",
"      Giannoudis PV, Grotz MR, Papakostidis C, Dinopoulos H. Operative treatment of displaced fractures of the acetabulum. A meta-analysis. J Bone Joint Surg Br 2005; 87:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/3\">",
"      Dente CJ, Feliciano DV, Rozycki GS, et al. The outcome of open pelvic fractures in the modern era. Am J Surg 2005; 190:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/4\">",
"      Hauschild O, Strohm PC, Culemann U, et al. Mortality in patients with pelvic fractures: results from the German pelvic injury register. J Trauma 2008; 64:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/5\">",
"      Cannada LK, Taylor RM, Reddix R, et al. The Jones-Powell Classification of open pelvic fractures: a multicenter study evaluating mortality rates. J Trauma Acute Care Surg 2013; 74:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/6\">",
"      Giannoudis PV, Grotz MR, Tzioupis C, et al. Prevalence of pelvic fractures, associated injuries, and mortality: the United Kingdom perspective. J Trauma 2007; 63:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/7\">",
"      Dechert TA, Duane TM, Frykberg BP, et al. Elderly patients with pelvic fracture: interventions and outcomes. Am Surg 2009; 75:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/8\">",
"      Sathy AK, Starr AJ, Smith WR, et al. The effect of pelvic fracture on mortality after trauma: an analysis of 63,000 trauma patients. J Bone Joint Surg Am 2009; 91:2803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/9\">",
"      Schulman JE, O'Toole RV, Castillo RC, et al. Pelvic ring fractures are an independent risk factor for death after blunt trauma. J Trauma 2010; 68:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/10\">",
"      Balogh Z, King KL, Mackay P, et al. The epidemiology of pelvic ring fractures: a population-based study. J Trauma 2007; 63:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/11\">",
"      Laird A, Keating JF. Acetabular fractures: a 16-year prospective epidemiological study. J Bone Joint Surg Br 2005; 87:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/12\">",
"      Demetriades D, Karaiskakis M, Toutouzas K, et al. Pelvic fractures: epidemiology and predictors of associated abdominal injuries and outcomes. J Am Coll Surg 2002; 195:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/13\">",
"      Kelsey JL, Prill MM, Keegan TH, et al. Risk factors for pelvis fracture in older persons. Am J Epidemiol 2005; 162:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/14\">",
"      Kimbrell BJ, Velmahos GC, Chan LS, Demetriades D. Angiographic embolization for pelvic fractures in older patients. Arch Surg 2004; 139:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/15\">",
"      Martin S, Casey N. Haemorrhage requiring embolisation after low energy pelvic fracture in an elderly patient: a case report. Emerg Med J 2010; 27:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/16\">",
"      Smith W, Williams A, Agudelo J, et al. Early predictors of mortality in hemodynamically unstable pelvis fractures. J Orthop Trauma 2007; 21:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/17\">",
"      Porter SE, Schroeder AC, Dzugan SS, et al. Acetabular fracture patterns and their associated injuries. J Orthop Trauma 2008; 22:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/18\">",
"      Kocher MS, Tucker R. Pediatric athlete hip disorders. Clin Sports Med 2006; 25:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/19\">",
"      Stein DM, O'Connor JV, Kufera JA, et al. Risk factors associated with pelvic fractures sustained in motor vehicle collisions involving newer vehicles. J Trauma 2006; 61:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/20\">",
"      Rowe SA, Sochor MS, Staples KS, et al. Pelvic ring fractures: implications of vehicle design, crash type, and occupant characteristics. Surgery 2004; 136:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/21\">",
"      G&auml;nsslen A, Giannoudis P, Pape HC. Hemorrhage in pelvic fracture: who needs angiography? Curr Opin Crit Care 2003; 9:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/22\">",
"      Magnussen RA, Tressler MA, Obremskey WT, Kregor PJ. Predicting blood loss in isolated pelvic and acetabular high-energy trauma. J Orthop Trauma 2007; 21:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/23\">",
"      Elzik ME, Dirschl DR, Dahners LE. Hemorrhage in pelvic fractures does not correlate with fracture length. J Trauma 2008; 65:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/24\">",
"      Salim A, Teixeira PG, DuBose J, et al. Predictors of positive angiography in pelvic fractures: a prospective study. J Am Coll Surg 2008; 207:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/25\">",
"      Bjurlin MA, Fantus RJ, Mellett MM, Goble SM. Genitourinary injuries in pelvic fracture morbidity and mortality using the National Trauma Data Bank. J Trauma 2009; 67:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/26\">",
"      Weis EB Jr. Subtle neurological injuries in pelvic fractures. J Trauma 1984; 24:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/27\">",
"      Denis F, Davis S, Comfort T. Sacral fractures: an important problem. Retrospective analysis of 236 cases. Clin Orthop Relat Res 1988; 227:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/28\">",
"      Schmal H, Hauschild O, Culemann U, et al. Identification of risk factors for neurological deficits in patients with pelvic fractures. Orthopedics 2010; 33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/29\">",
"      Bramos A, Velmahos GC, Butt UM, et al. Predictors of bleeding from stable pelvic fractures. Arch Surg 2011; 146:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/30\">",
"      Burgess AR, Eastridge BJ, Young JW, et al. Pelvic ring disruptions: effective classification system and treatment protocols. J Trauma 1990; 30:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/31\">",
"      Sarin EL, Moore JB, Moore EE, et al. Pelvic fracture pattern does not always predict the need for urgent embolization. J Trauma 2005; 58:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/32\">",
"      Lunsjo K, Tadros A, Hauggaard A, et al. Associated injuries and not fracture instability predict mortality in pelvic fractures: a prospective study of 100 patients. J Trauma 2007; 62:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/33\">",
"      Manson T, O'Toole RV, Whitney A, et al. Young-Burgess classification of pelvic ring fractures: does it predict mortality, transfusion requirements, and non-orthopaedic injuries? J Orthop Trauma 2010; 24:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/34\">",
"      Letournel E. Acetabulum fractures: classification and management. Clin Orthop Relat Res 1980; :81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/35\">",
"      Esposito TJ, Ingraham A, Luchette FA, et al. Reasons to omit digital rectal exam in trauma patients: no fingers, no rectum, no useful additional information. J Trauma 2005; 59:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/36\">",
"      Shlamovitz GZ, Mower WR, Bergman J, et al. How (un)useful is the pelvic ring stability examination in diagnosing mechanically unstable pelvic fractures in blunt trauma patients? J Trauma 2009; 66:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/37\">",
"      Gonzalez RP, Fried PQ, Bukhalo M. The utility of clinical examination in screening for pelvic fractures in blunt trauma. J Am Coll Surg 2002; 194:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/38\">",
"      Duane TM, Tan BB, Golay D, et al. Blunt trauma and the role of routine pelvic radiographs: a prospective analysis. J Trauma 2002; 53:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/39\">",
"      McCormick JP, Morgan SJ, Smith WR. Clinical effectiveness of the physical examination in diagnosis of posterior pelvic ring injuries. J Orthop Trauma 2003; 17:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/40\">",
"      Pehle B, Nast-Kolb D, Oberbeck R, et al. [Significance of physical examination and radiography of the pelvis during treatment in the shock emergency room]. Unfallchirurg 2003; 106:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/41\">",
"      Leggon RE, Wood GC, Indeck MC. Pelvic fractures in pregnancy: factors influencing maternal and fetal outcomes. J Trauma 2002; 53:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/42\">",
"      Friese RS, Malekzadeh S, Shafi S, et al. Abdominal ultrasound is an unreliable modality for the detection of hemoperitoneum in patients with pelvic fracture. J Trauma 2007; 63:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/43\">",
"      Tayal VS, Nielsen A, Jones AE, et al. Accuracy of trauma ultrasound in major pelvic injury. J Trauma 2006; 61:1453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/44\">",
"      Davis JW, Moore FA, McIntyre RC Jr, et al. Western trauma association critical decisions in trauma: management of pelvic fracture with hemodynamic instability. J Trauma 2008; 65:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/45\">",
"      Kessel B, Sevi R, Jeroukhimov I, et al. Is routine portable pelvic X-ray in stable multiple trauma patients always justified in a high technology era? Injury 2007; 38:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/46\">",
"      Vo NJ, Gash J, Browning J, Hutson RK. Pelvic imaging in the stable trauma patient: is the AP pelvic radiograph necessary when abdominopelvic CT shows no acute injury? Emerg Radiol 2004; 10:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/47\">",
"      Obaid AK, Barleben A, Porral D, et al. Utility of plain film pelvic radiographs in blunt trauma patients in the emergency department. Am Surg 2006; 72:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/48\">",
"      Barleben A, Jafari F, Rose J Jr, et al. Implementation of a cost-saving algorithm for pelvic radiographs in blunt trauma patients. J Trauma 2011; 71:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/49\">",
"      Gardner MJ, Krieg JC, Simpson TS, Bottlang M. Displacement after simulated pelvic ring injuries: a cadaveric model of recoil. J Trauma 2010; 68:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/50\">",
"      Starks I, Frost A, Wall P, Lim J. Is a fracture of the transverse process of L5 a predictor of pelvic fracture instability? J Bone Joint Surg Br 2011; 93:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/51\">",
"      Mohseni S, Talving P, Kobayashi L, et al. The diagnostic accuracy of 64-slice computed tomography in detecting clinically significant arterial bleeding after pelvic fractures. Am Surg 2011; 77:1176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/52\">",
"      Dormagen JB, T&ouml;tterman A, R&oslash;ise O, et al. Efficacy of plain radiography and computer tomography in localizing the site of pelvic arterial bleeding in trauma patients. Acta Radiol 2010; 51:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/53\">",
"      Burlew CC, Moore EE, Smith WR, et al. Preperitoneal pelvic packing/external fixation with secondary angioembolization: optimal care for life-threatening hemorrhage from unstable pelvic fractures. J Am Coll Surg 2011; 212:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/54\">",
"      Martinelli T, Thony F, Decl&eacute;ty P, et al. Intra-aortic balloon occlusion to salvage patients with life-threatening hemorrhagic shocks from pelvic fractures. J Trauma 2010; 68:942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/55\">",
"      Gardner MJ, Parada S, Chip Routt ML Jr. Internal rotation and taping of the lower extremities for closed pelvic reduction. J Orthop Trauma 2009; 23:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/56\">",
"      Routt ML Jr, Falicov A, Woodhouse E, Schildhauer TA. Circumferential pelvic antishock sheeting: a temporary resuscitation aid. J Orthop Trauma 2002; 16:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/57\">",
"      Lee C, Porter K. The prehospital management of pelvic fractures. Emerg Med J 2007; 24:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/58\">",
"      Krieg JC, Mohr M, Ellis TJ, et al. Emergent stabilization of pelvic ring injuries by controlled circumferential compression: a clinical trial. J Trauma 2005; 59:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/59\">",
"      Durkin A, Sagi HC, Durham R, Flint L. Contemporary management of pelvic fractures. Am J Surg 2006; 192:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/60\">",
"      Shore BJ, Palmer CS, Bevin C, et al. Pediatric pelvic fracture: a modification of a preexisting classification. J Pediatr Orthop 2012; 32:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/61\">",
"      Keshishyan RA, Rozinov VM, Malakhov OA, et al. Pelvic polyfractures in children. Radiographic diagnosis and treatment. Clin Orthop Relat Res 1995; :28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/62\">",
"      Ismail N, Bellemare JF, Mollitt DL, et al. Death from pelvic fracture: children are different. J Pediatr Surg 1996; 31:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/63\">",
"      G&auml;nsslen A, Hildebrand F, Heidari N, Weinberg AM. Pelvic ring injuries in children. Part I: Epidemiology and primary evaluation. A review of the literature. Acta Chir Orthop Traumatol Cech 2012; 79:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/64\">",
"      Leonard M, Ibrahim M, Mckenna P, et al. Paediatric pelvic ring fractures and associated injuries. Injury 2011; 42:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/65\">",
"      Guillamondegui OD, Mahboubi S, Stafford PW, Nance ML. The utility of the pelvic radiograph in the assessment of pediatric pelvic fractures. J Trauma 2003; 55:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/66\">",
"      Lagisetty J, Slovis T, Thomas R, et al. Are routine pelvic radiographs in major pediatric blunt trauma necessary? Pediatr Radiol 2012; 42:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/67\">",
"      Wong AT, Brady KB, Caldwell AM, et al. Low-risk criteria for pelvic radiography in pediatric blunt trauma patients. Pediatr Emerg Care 2011; 27:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/7/22650/abstract/68\">",
"      Smith WR, Oakley M, Morgan SJ. Pediatric pelvic fractures. J Pediatr Orthop 2004; 24:130.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 360 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-E01451B0F0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22650=[""].join("\n");
var outline_f22_7_22650=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H34\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Incidence and mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Mechanisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Associated injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      FRACTURE TYPES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Pelvic ring disruptions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Sacral fracture classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Acetabular fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Avulsion fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PREHOSPITAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      INITIAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Initial assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Diagnostic peritoneal aspirate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Plain radiograph",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - CT Scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Retrograde cystourethrogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Initial stabilization and approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Pelvis injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Acetabular injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Avulsion injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13255578\">",
"      - Minor pelvic fractures in elders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Pitfalls and pearls",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      DEFINITIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Specialty consultation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Transfer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7468319\">",
"      PEDIATRIC CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6979610\">",
"      Anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7468335\">",
"      Epidemiology and mechanism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7468357\">",
"      Associated injuries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7468372\">",
"      Imaging studies and fracture types",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7468393\">",
"      Evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7468407\">",
"      Outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3484032\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/360\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/360|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?36/40/37518\" title=\"algorithm 1\">",
"      Pelvic trauma algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/360|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/9/19605\" title=\"diagnostic image 1\">",
"      Pelvic lateral compression fracture type I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/33/27154\" title=\"diagnostic image 2\">",
"      Pelvic lateral compression fracture type II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/62/44005\" title=\"diagnostic image 3\">",
"      Pelvic lateral compression fracture type III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/39/39537\" title=\"diagnostic image 4\">",
"      Pelvic AP compression fracture type I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/62/23522\" title=\"diagnostic image 5\">",
"      Pelvic anteroposterior compression fracture type II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/52/21317\" title=\"diagnostic image 6\">",
"      Pelvic AP compression fracture type II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/49/10005\" title=\"diagnostic image 7\">",
"      Pelvic AP compression fracture type",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/41/11921\" title=\"diagnostic image 8\">",
"      Pelvic vertical shear injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/41/28309\" title=\"diagnostic image 9\">",
"      Pelvic vertical shear fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/32/13824\" title=\"diagnostic image 10\">",
"      Open book fracture pubic symphysis diastasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/5/44112\" title=\"diagnostic image 11\">",
"      Open book pelvic fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/10/10405\" title=\"diagnostic image 12\">",
"      Radiographic views for acetabular fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/22/12643\" title=\"diagnostic image 13\">",
"      Acetabular fracture of posterior column",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/56/32642\" title=\"diagnostic image 14\">",
"      Posterior acetabular and femoral head fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/50/27427\" title=\"diagnostic image 15\">",
"      Anterior acetabular wall fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/17/33044\" title=\"diagnostic image 16\">",
"      Anterior acetabular column fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/24/41345\" title=\"diagnostic image 17\">",
"      Acetabular transverse and posterior wall fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/31/30194\" title=\"diagnostic image 18\">",
"      T-shaped acetabular fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/9/41109\" title=\"diagnostic image 19\">",
"      Acetabular posterior wall and column fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/4/41028\" title=\"diagnostic image 20\">",
"      Transverse acetabular fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/3/12340\" title=\"diagnostic image 21\">",
"      Anterior column and hemitransverse acetabular fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/16/34049\" title=\"diagnostic image 22\">",
"      Acetabular fracture of anterior and posterior columns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/56/42880\" title=\"diagnostic image 23\">",
"      Iliac spine avulsion fracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/360|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/17/26900\" title=\"figure 1\">",
"      Anterior and posterior columns of acetabulum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/29/16850\" title=\"figure 2\">",
"      Pelvic ligaments anterior and posterior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/56/6026\" title=\"figure 3\">",
"      Bones and ligaments of the pelvis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/35/22069\" title=\"figure 4\">",
"      Pelvic bones and female organs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/10/4265\" title=\"figure 5\">",
"      Pelvic arteries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/19/12600\" title=\"figure 6\">",
"      Pelvic arteries nerve roots",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/35/36408\" title=\"figure 7\">",
"      Pelvic veins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/7/10362\" title=\"figure 8\">",
"      Pelvic nerve plexus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/1/36887\" title=\"figure 9\">",
"      Pelvic somatic nerves",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/40/27268\" title=\"figure 10\">",
"      Pelvic ring fracture classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/37/16985\" title=\"figure 11\">",
"      Acetabular fracture general classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/41/44694\" title=\"figure 12\">",
"      Classification of simple acetabular fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/61/14295\" title=\"figure 13\">",
"      Classification of complex acetabular fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/26/35232\" title=\"figure 14\">",
"      Pelvic inlet view xray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/25/40336\" title=\"figure 15\">",
"      Pelvic outlet view xray",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/360|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/31/19958\" title=\"picture 1\">",
"      Binding injured pelvis with sheet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/34/44580\" title=\"picture 2\">",
"      Pelvic sling SAM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/360|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/42/31404\" title=\"table 1\">",
"      LS nerve muscle function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/61/38875\" title=\"table 2\">",
"      Young and Burgess classification of pelvic fractures",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/63/18425?source=related_link\">",
"      Blunt genitourinary trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/30/7658?source=related_link\">",
"      Emergency ultrasound in adults with abdominal and thoracic trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=related_link\">",
"      Initial evaluation and management of blunt abdominal trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/11/35002?source=related_link\">",
"      Initial management of trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/2/33831?source=related_link\">",
"      Minor pelvic fractures in the elderly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=related_link\">",
"      Overview of blunt abdominal trauma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/21/5459?source=related_link\">",
"      Patient information: Pelvic fracture (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/4/17482?source=related_link\">",
"      Prehospital care of the adult trauma patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/16/25865?source=related_link\">",
"      Severe pelvic fracture in the adult trauma patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22569?source=related_link\">",
"      Trauma in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29962?source=related_link\">",
"      Trauma management: Approach to the unstable child",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3477?source=related_link\">",
"      Trauma management: Unique pediatric considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/25/10646?source=related_link\">",
"      Treatment and prevention of osteomyelitis following trauma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_7_22651="Acute Rx severe UGI bleeding";
var content_f22_7_22651=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F52860&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F52860&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Acute management of severe upper gastrointestinal bleeding",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        1. Resuscitation and stabilization, initiation of medical therapy with an intravenous proton pump inhibitor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Assessment of onset and severity of bleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Risk stratification using validated prognostic scale",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        4. Diagnostic endoscopy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Preparation for emergent upper endoscopy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Localization and identification of the bleeding site",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Idenification of stigmata of recent hemorrhage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Stratification of the risk for rebleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        4. Therapeutic endoscopy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Control of active bleeding or high-risk lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Minimization of treatment-related complications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Treatment of persistent or recurrent bleeding",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22651=[""].join("\n");
var outline_f22_7_22651=null;
var title_f22_7_22652="HTN with VEGF inhib";
var content_f22_7_22652=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F73373&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F73373&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for initial assessment, surveillance, and management of blood pressure in patients receiving VEGF (vascular endothelial growth factor) signaling pathway inhibitors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Pretreatment assessment and screening",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Standardized blood pressure measurements, preferably on two separate occasions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. History and physical examination for formal assessment of specific cardiovascular risk factors, more detailed laboratory and/or diagnostic tests may be required to adequately screen for cardiovascular risks (eg, lipid panel, electrocardiogram)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Use this information to determine the appropriate intensity of monitoring and target for blood pressure control during therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. Treat preexisting hypertension and address other comorbidities that might, through more attentive management, prolong life and support more aggressive cancer therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Monitoring during treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Actively monitor blood pressure throughout treatment with more frequent assessments during the first cycle (when the bulk of blood pressure elevation is expected to occur)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Monitoring every two to three weeks after the first cycle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Management",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Patients who develop hypertension during therapy (&ge;140 mmHg/90 Hg, or increases in diastolic blood pressure &ge;20 mm from baseline) should initiate anti-hypertensive therapy, have current therapy titrated to better control blood pressure, or have another agent added. The goal for blood pressure in patients receiving VEGF inhibitors is maximum blood pressure of 140/90. Target should be adjusted lower for patients with preexisting risk factors for adverse consequences of high blood pressure (eg, diabetes, chronic kidney disease).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Manage blood pressure elevations aggressively to avoid complications, pay attention to agent selection, dose and scheduling of follow-up visits to control adverse effects of the antihypertensive agent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Consultation with a hypertension specialist may be needed if there is difficulty achieving goal blood pressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. Consider discontinuation or dose reduction of VEGF inhibitor therapy if diastolic blood pressure is not controlled with anti-hypertensive medication",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Maitland ML, Bakris GL, Black HR, et al. Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors. J Natl Cancer Inst 2010; 102:596.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22652=[""].join("\n");
var outline_f22_7_22652=null;
var title_f22_7_22653="Asthma severity 12 and up";
var content_f22_7_22653=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F71425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F71425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classifying asthma severity in youths greater than or equal to 12 years of age and adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"3\">",
"        Components of severity",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Classification of asthma severity (youths &ge;12 years of age and adults)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\" rowspan=\"2\">",
"        Intermittent",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"4\">",
"        Persistent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3\">",
"        Mild",
"       </td>",
"       <td class=\"subtitle3\">",
"        Moderate",
"       </td>",
"       <td class=\"subtitle3\">",
"        Severe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        <p>",
"         Impairment",
"        </p>",
"        <p>",
"         Normal FEV",
"         <sub>",
"          1",
"         </sub>",
"         /FVC:",
"        </p>",
"        <p>",
"         8-19 yr 85 percent",
"        </p>",
"        <p>",
"         20-39 yr 80 percent",
"        </p>",
"        <p>",
"         40-59 yr 75 percent",
"        </p>",
"        <p>",
"         60-80 yr 70 percent",
"        </p>",
"       </td>",
"       <td>",
"        Symptoms",
"       </td>",
"       <td>",
"        &le;2 days/week",
"       </td>",
"       <td>",
"        &gt;2 days/week but not daily",
"       </td>",
"       <td>",
"        Daily",
"       </td>",
"       <td>",
"        Throughout the day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nighttime awakenings",
"       </td>",
"       <td>",
"        &le;2x/month",
"       </td>",
"       <td>",
"        3-4x/month",
"       </td>",
"       <td>",
"        &gt;1x/week but not nightly",
"       </td>",
"       <td>",
"        Often 7x/week",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Short-acting beta",
"        <sub>",
"         2",
"        </sub>",
"        -agonist use for symptom control (not prevention of EIB)",
"       </td>",
"       <td>",
"        &le;2 days/week",
"       </td>",
"       <td>",
"        &gt;2 days/week but not &gt;1x/day",
"       </td>",
"       <td>",
"        Daily",
"       </td>",
"       <td>",
"        Several times per day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interference with normal activity",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Minor limitation",
"       </td>",
"       <td>",
"        Some limitation",
"       </td>",
"       <td>",
"        Extremely limited",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lung function",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Normal FEV",
"         <sub>",
"          1",
"         </sub>",
"         between exacerbations",
"        </p>",
"        <p>",
"         &bull; FEV",
"         <sub>",
"          1",
"         </sub>",
"         &gt;80 percent predicted",
"        </p>",
"        <p>",
"         &bull; FEV",
"         <sub>",
"          1",
"         </sub>",
"         /FVC normal",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         &bull; FEV",
"         <sub>",
"          1",
"         </sub>",
"         &ge;80 percent predicted",
"        </p>",
"        <p>",
"         &bull; FEV",
"         <sub>",
"          1",
"         </sub>",
"         /FVC normal",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         &bull; FEV",
"         <sub>",
"          1",
"         </sub>",
"         &gt;60 but &lt;80 percent predicted",
"        </p>",
"        <p>",
"         &bull; FEV",
"         <sub>",
"          1",
"         </sub>",
"         /FVC reduced 5 percent",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         &bull; FEV",
"         <sub>",
"          1",
"         </sub>",
"         &lt;60 percent predicted",
"        </p>",
"        <p>",
"         &bull; FEV",
"         <sub>",
"          1",
"         </sub>",
"         /FVC reduced &gt;5 percent",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Risk",
"       </td>",
"       <td rowspan=\"4\">",
"        <strong>",
"         Exacerbations requiring oral systemic corticosteroids",
"        </strong>",
"       </td>",
"       <td>",
"        <strong>",
"         0-1/year (see footnote)",
"        </strong>",
"       </td>",
"       <td colspan=\"3\">",
"        <strong>",
"         &ge;2/year (see footnote)",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         Consider severity and interval since last exacerbation",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         Frequency and severity may fluctuate over time for patients in any severity category",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         Relative annual risk of exacerbations may be related to FEV",
"         <sub>",
"          1",
"         </sub>",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     Classifying severity for patients who are not currently taking long-term control medications.",
"    </strong>",
"    Level of severity is determined by assessment of both impairment and risk. Assess impairment domain by patient's/caregiver's recall of previous 2-4 weeks and spirometry. Assign severity to the most severe category in which any feature occurs. At present, there are inadequate data to correspond frequencies of exacerbations with different levels of asthma severity. In general, more frequent and intense exacerbations (eg, requiring urgent, unscheduled care, hospitalization, or ICU admission) indicate greater underlying disease severity. For treatment purposes, patients who had &ge;2 exacerbations requiring oral systemic corticosteroids in the past year may be considered the same as patients who have persistent asthma, even in the absence of impairment levels consistent with persistent asthma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: National Heart, Blood, and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma. NIH Publication no. 08-4051, 2007.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22653=[""].join("\n");
var outline_f22_7_22653=null;
var title_f22_7_22654="Estimates of the benefits and risks of tamoxifen";
var content_f22_7_22654=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F80306&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F80306&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Estimates of the benefits and risks of tamoxifen",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 398px; height: 322px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tamoxifen decreased the average annual rate of breast cancer in the Breast Cancer Prevention Trial, but increased the rate of endometrial cancer and vascular events such as stroke, pulmonary embolism, and deep vein thrombosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Fisher B, Costantino JP, Wikerham DL. J Natl Cancer Inst 1998; 90:1371.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22654=[""].join("\n");
var outline_f22_7_22654=null;
var title_f22_7_22655="Management of HIV patients with CNS lesions algorithm";
var content_f22_7_22655=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F50593&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F50593&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 543px\">",
"   <div class=\"ttl\">",
"    Algorithm for the management of HIV-infected patients with central nervous system mass lesions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 523px; height: 512px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Elements in",
"    <strong>",
"     bold",
"    </strong>",
"    represent data which contribute to the decision-making process (see text for details).",
"    <div class=\"footnotes\">",
"     Toxo: Toxoplasma encephalitis; LP: lumbar puncture; CSF: cerebrospinal fluid; Rx: treatment.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_7_22655=[""].join("\n");
var outline_f22_7_22655=null;
